Congenital Zika Syndrome

Infectious Disease MONDO:0000890 Pathograph 13 Show in embeddings browser Microcephaly

Congenital Zika syndrome (CZS) is a non-genetic malformation of cortical development caused by intrauterine infection with Zika virus (ZIKV), a mosquito-borne flavivirus. After maternal infection — most consequential for fetal neurodevelopment during the first and second trimesters — ZIKV crosses the placenta and reaches the developing fetal central nervous system, where it is neurotropic for apical and outer radial glia and other neural progenitor cells of the cortical ventricular and subventricular zones. Productive infection of these founder progenitors dysregulates the cell cycle, triggers caspase-mediated apoptosis, and activates innate antiviral signalling (including the TLR3 pathway and type I interferon responses), collectively depleting the progenitor pool and abrogating neurogenesis during the peak neurogenic window. The resulting deficit of cortical neurons produces the recognizable CZS phenotype: severe (often congenital) microcephaly with a markedly disproportionate skull, agyria/lissencephaly-like smooth cortex, intracranial (cortical and subcortical) calcifications, ventriculomegaly/hydrocephalus, and cortical thinning, frequently accompanied by ocular abnormalities, arthrogryposis, sensorineural hearing loss, seizures, and global developmental delay. CZS is the exemplar infectious (non-Mendelian) cortical malformation mechanism: its proximal cause is a defined viral exposure rather than a germline variant, but it converges on the same progenitor-depletion endpoint as genetic primary microcephaly, distinguished pathologically by a more destructive process with prominent cell death, necrosis, and calcification.

Ask OpenScientist

Ask a research question about Congenital Zika Syndrome. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

12
Pathophys.
1
Histopath.
14
Phenotypes
5
Gaps
13
Pathograph
2
Medical Actions
2
Differentials
3
Datasets
1
Models
24
References
1
Deep Research
?

Discussions and Knowledge Gaps

5
Which parts of the congenital Zika syndrome mechanism are directly supported in human fetal disease, and which remain model-dependent findings from human iPSC-derived neural progenitors, cerebral organoids, mouse embryos, non-human-primate organoids, or organotypic fetal systems?
HUMAN MODEL MISMATCH OPEN gap_czs_human_model_translatability
The disease pathograph now conforms to the viral neural progenitor cytopathy module, but much of the causal resolution comes from experimental systems rather than longitudinal human fetal material. Human autopsy anchors viral brain invasion and destructive malformation, while iPSC-derived hNPCs, cerebral organoids, mouse embryos, and non-human-primate organoids resolve entry, TLR3/TBK1 signaling, centrosome perturbation, apoptosis, and strain adaptation. This gap prevents a single model system from being treated as complete proof of the human prenatal disease sequence.
Proposed experiments
CZS cross-model fetal-brain alignment experiment
cross-model viral cortical malformation alignment experiment Relation: this experiment is of type this experiment type This experiment is of type cross-model viral cortical malformation alignment experiment.
exp_czs_cross_model_fetal_alignment
Compare matched ZIKV strains across human iPSC-derived cortical organoids, hNPC/radial-glial cultures, ethically available fetal cortical tissue or organotypic slices, and susceptible in vivo models, then map viral tropism, TLR3/TBK1 signaling, centrosome perturbation, apoptosis, progenitor loss, neurogenesis, and cortical thinning against human fetal autopsy endpoints.
Model systems
Human iPSC-derived cortical organoid ZIKV model
Three-dimensional human cortical organoid system containing radial glia, neural progenitors, and early cortical neurons exposed to clinically relevant ZIKV strains.
human NCBITaxon:9606 NCBI Taxonomy (NCBITaxon) Relation: this experimental model is built in this organism This experimental model is built in human, annotated with Homo sapiens (NCBITaxon:9606). NCBITaxon:9606 is an organism from the NCBI Taxonomy.
cerebral cortex UBERON:0000956 Uberon multi-species anatomy ontology (UBERON) Relation: this experimental model uses this anatomical location This experimental model uses cerebral cortex (UBERON:0000956). UBERON:0000956 is an anatomical location from the Uberon multi-species anatomy ontology.
radial glial cell CL:0000681 Cell Ontology (CL) Relation: this experimental model uses this cell type This experimental model uses radial glial cell (CL:0000681). CL:0000681 is a cell type from the Cell Ontology. neural progenitor cell CL:0011020 Cell Ontology (CL) Relation: this experimental model uses this cell type This experimental model uses neural progenitor cell (CL:0011020). CL:0011020 is a cell type from the Cell Ontology.
Human fetal cortical tissue benchmark
Postmortem or organotypic fetal cortical material, where ethically and legally available, used as a benchmark for viral localization, radial glial vulnerability, apoptosis, calcification, and cortical tissue architecture.
PRIMARY CELL CULTURE
human NCBITaxon:9606 NCBI Taxonomy (NCBITaxon) Relation: this experimental model is built in this organism This experimental model is built in human, annotated with Homo sapiens (NCBITaxon:9606). NCBITaxon:9606 is an organism from the NCBI Taxonomy.
cerebral cortex UBERON:0000956 Uberon multi-species anatomy ontology (UBERON) Relation: this experimental model uses this anatomical location This experimental model uses cerebral cortex (UBERON:0000956). UBERON:0000956 is an anatomical location from the Uberon multi-species anatomy ontology.
radial glial cell CL:0000681 Cell Ontology (CL) Relation: this experimental model uses this cell type This experimental model uses radial glial cell (CL:0000681). CL:0000681 is a cell type from the Cell Ontology. neural progenitor cell CL:0011020 Cell Ontology (CL) Relation: this experimental model uses this cell type This experimental model uses neural progenitor cell (CL:0011020). CL:0011020 is a cell type from the Cell Ontology.
Perturbations
Matched congenital ZIKV strain exposure
Expose model systems to matched congenital outbreak isolates and laboratory-passaged controls under controlled inoculum and developmental timing.
Readouts
Viral tropism and replication in radial glia and neural progenitors
viral genome replication GO:0019079 Gene Ontology (GO) Relation: this readout reports on this biological process This readout reports on increased viral genome replication (GO:0019079). GO:0019079 is a biological process from the Gene Ontology. ↑ INCREASED
viral RNA quantification Relation: this readout is measured by this assay This readout is measured by viral RNA quantification. immunostaining Relation: this readout is measured by this assay This readout is measured by immunostaining. single-cell RNA sequencing Relation: this readout is measured by this assay This readout is measured by single-cell RNA sequencing.
Direction: POSITIVE
Innate immune and centrosome cytopathy
toll-like receptor signaling pathway GO:0002224 Gene Ontology (GO) Relation: this readout reports on this biological process This readout reports on increased toll-like receptor signaling pathway (GO:0002224). GO:0002224 is a biological process from the Gene Ontology. ↑ INCREASED centrosome cycle GO:0007098 Gene Ontology (GO) Relation: this readout reports on this biological process This readout reports on abnormal centrosome cycle (GO:0007098). GO:0007098 is a biological process from the Gene Ontology. ⚠ ABNORMAL
phospho-TBK1 localization assay Relation: this readout is measured by this assay This readout is measured by phospho-TBK1 localization assay. centrosome immunostaining Relation: this readout is measured by this assay This readout is measured by centrosome immunostaining. single-cell RNA sequencing Relation: this readout is measured by this assay This readout is measured by single-cell RNA sequencing.
Direction: POSITIVE
Progenitor survival and cortical growth
apoptotic process GO:0006915 Gene Ontology (GO) Relation: this readout reports on this biological process This readout reports on increased apoptotic process (GO:0006915). GO:0006915 is a biological process from the Gene Ontology. ↑ INCREASED neurogenesis GO:0022008 Gene Ontology (GO) Relation: this readout reports on this biological process This readout reports on decreased neurogenesis (GO:0022008). GO:0022008 is a biological process from the Gene Ontology. ↓ DECREASED
cleaved caspase-3 immunostaining Relation: this readout is measured by this assay This readout is measured by cleaved caspase-3 immunostaining. progenitor and neuron marker quantification Relation: this readout is measured by this assay This readout is measured by progenitor and neuron marker quantification. cortical thickness measurement Relation: this readout is measured by this assay This readout is measured by cortical thickness measurement.
Direction: NEGATIVE
Controls
Mock-infected controls
Matched model systems exposed to vehicle without infectious virus.
Strain-matched heat-inactivated viral controls
Controls for innate immune stimulation not requiring productive infection.
Decision criterion
The CZS mechanism is strengthened if human organoids, fetal tissue benchmarks, and susceptible in vivo models show concordant radial-glial or progenitor tropism, TLR3/TBK1 and centrosome perturbation, apoptosis, progenitor depletion, reduced neurogenesis, and cortical thinning under matched strain and developmental timing. Major divergence would localize model-specific branches that should not be generalized to human CZS.
Show evidence (2 references)
PMID:27279226 SUPPORT Other
"Mouse models often fail to reproduce the severely reduced brain size and pathological alterations found in human patients21,22, likely due to significant differences in gestation time and brain development between the two species."
The paper explicitly identifies species and developmental-context differences that limit translation from mouse CZS models.
PMID:27279226 SUPPORT In Vitro
"Finally, our data using a non-human primate organoids suggested that the ZIKVBR might have experienced adaptive changes in human cells."
Supports a strain- and host-cell-context mismatch gap for translating organoid and animal findings to human congenital infection.
No approved antiviral or disease-modifying therapy exists for congenital Zika syndrome; candidate small molecules (e.g., nucleoside analogues) and TLR3-pathway modulation have shown effects only in experimental models. Which interventions, if any, can interrupt the progenitor-cytopathy cascade within the narrow prenatal therapeutic window?
KNOWLEDGE GAP OPEN gap_czs_specific_therapy
Experimental evidence (e.g., TLR3 inhibition reducing ZIKV phenotypes in organoids) suggests mechanistically rational intervention points, but no therapy has translated to human prenatal use, and the destructive, early-onset nature of the progenitor cytopathy makes the therapeutic window extremely narrow. This gap motivates prevention (vector control, avoidance of exposure in pregnancy) as the current mainstay.
Does tunneling-nanotube-mediated viral spread operate in the human placenta, and how much of the mouse placental-injury phenotype transfers to human congenital Zika disease?
HUMAN MODEL MISMATCH OPEN mismatch_czs_tnt_placental_transmission
The TNT arm of transplacental dissemination is established entirely in mouse pregnancy models, by comparing a TNT-competent virus with an NS1 residue-40-52 TNT-deficient mutant. Two distinct translational questions follow. First, TNTs have not been demonstrated to carry ZIKV between cells in human placental tissue in vivo, so the mechanism is a strong candidate rather than an established human route. Second, and more concretely, the architectural readout does not transfer at all: the junctional zone and labyrinth are compartments of the rodent placenta with no direct human homolog, so "altered junctional-to-labyrinth architecture" cannot be restated as a human placental finding. The nearest human comparison points the other way: in full-term placentas from three ZIKV-infected women, viral NS3 antigen localized to Hofbauer cells while the placentas showed no anatomic defects (PMID:31709049, the publication behind the GSE139181 dataset already curated in this entry) — a small series, and not a test of the TNT mechanism, but not obviously the same picture either. Fetal growth restriction is therefore curated as an ORGANISM-scale pathophysiology node carrying model-organism evidence, and is deliberately absent from `phenotypes:`, which would require human evidence.
Proposed experiments
Detection of ZIKV-laden tunneling nanotubes in human placental explants
exp_czs_tnt_human_placenta
Live imaging and correlative electron microscopy of ZIKV-infected primary human trophoblast and placental explant cultures, scoring actin-rich intercellular conduits carrying viral components, with the NS1 residue-40-52 TNT-deficient mutant as the negative control.
Show evidence (3 references)
PMID:42627154 SUPPORT Model Organism
"Here, we investigated the in vivo role of TNTs in ZIKV maternal-fetal transmission using complementary pregnancy models."
Establishes that the in vivo evidence for the TNT arm comes from animal pregnancy models rather than human tissue.
PMID:42627154 SUPPORT Model Organism
"ZIKVΔTNT infection was associated with reduced placental pathology, altered junctional-to-labyrinth architecture, improved placental efficiency, and protection from fetal growth restriction."
Names the junctional-to-labyrinth readout, which is a rodent placental compartment measure with no human equivalent.
PMID:31709049 SUPPORT Human Clinical
"Although ZIKV NS3 antigens co-localised to placental Hofbauer cells, the placentas showed no anatomic defects."
The human placental comparison invoked in this mismatch. Infected human placentas carried viral antigen without the structural defects the mouse models show.
Is the NS1 determinant of tunneling-nanotube formation (residues 40-52) a tractable antiviral target for preventing transplacental ZIKV transmission, and does the same TNT route operate in other vertically transmitted viruses?
KNOWLEDGE GAP OPEN gap_czs_ns1_tnt_therapeutic_target
A discrete viral protein determinant whose loss reduces dissemination, placental injury, and fetal growth restriction without abolishing viral viability is an unusually clean target hypothesis, and it addresses the transmission step rather than the downstream progenitor cytopathy — a much wider therapeutic window than the one the existing therapy gap describes. Nothing here has been tested as an intervention: the evidence is a genetically engineered mutant virus, not a drug or an antibody, and no NS1-directed agent has been shown to block TNT formation. The authors also raise, without testing, whether TNTs matter for other vertically transmitted or emerging viruses; that generalization has no evidence in this entry and should not be curated onto other disease entries on the strength of this paper alone.
Show evidence (2 references)
PMID:42627154 SUPPORT Model Organism
"These findings identify TNTs as a previously underappreciated pathway of viral transmission during pregnancy and suggest new therapeutic targets."
The therapeutic-target claim is the authors' proposal, not a tested intervention, which is what makes this a gap rather than a treatment entry.
PMID:42627154 SUPPORT Model Organism
"More broadly, TNTs may contribute to the pathogenesis of other vertically transmitted or emerging viral infections."
Records the cross-pathogen generalization as an explicitly speculative statement.
Does pre-existing maternal dengue immunity worsen fetal outcome in human congenital Zika syndrome, as it does in macaques?
HUMAN MODEL MISMATCH OPEN gap_czs_dengue_immunity_enhancement
Why some ZIKV-exposed fetuses are severely affected and others are not is the largest unexplained variance in this disease, and the entry's timing account does not fully cover it. A nonhuman primate experiment supplies a candidate: fetuses of dengue-immune macaques infected in early pregnancy developed significantly worse CZS than naive controls, with no difference in maternal infection or antibody response — locating the effect in the fetus rather than in maternal viral control. The translational question is unusually consequential because ZIKV and DENV co-circulate across most of the affected geography, so a large share of women entering a Zika outbreak are dengue-immune. If the enhancement operates in humans, prior dengue serostatus would be a risk stratifier available before conception and would also bear on flavivirus vaccination strategy in women of childbearing age. If it does not, the macaque result localises a species-specific branch that should not inform human counselling. This is recorded as a mismatch rather than a knowledge gap because the evidence exists and is strong in the model; what is unknown is whether it transfers.
Proposed experiments
DENV-serostatus-stratified prospective cohort of ZIKV-infected pregnancies
exp_czs_denv_serostatus_stratified_cohort
In a prospective cohort of pregnancies with confirmed ZIKV infection, determine pre-pregnancy or first-trimester DENV serostatus and compare the incidence and severity of CZS between DENV-immune and DENV-naive mothers, stratifying by gestational age at infection so the two risk factors are not confounded.
Supporting outcome
  • CZS is more frequent or more severe in the offspring of DENV-immune mothers after adjustment for timing, supporting transfer of the macaque enhancement to human pregnancy.
Refuting outcome
  • CZS incidence and severity are independent of maternal DENV serostatus, indicating the enhancement is model-specific and should not be used for human risk stratification.

Pathophysiology

12
Tunneling Nanotube-Mediated Intercellular Viral Spread
ZIKV induces tunneling nanotubes (TNTs) — actin-rich, membrane-bounded intercellular conduits that carry viral components directly from cell to cell, bypassing the extracellular space. TNT-forming capacity maps to residues 40-52 of the viral nonstructural protein NS1: an engineered TNT-deficient mutant (ZIKVΔTNT) disseminates markedly less to maternal and fetal tissues than TNT-competent virus across multiple pregnancy models. Because transfer through a TNT is shielded from the extracellular compartment, this route also appears to let the virus persist in the face of a maternal type III interferon (IFN-lambda) response, implicating TNTs in immune evasion as well as in spread.
tunneling nanotube formation GO:0120031 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves increased tunneling nanotube formation, annotated with plasma membrane bounded cell projection assembly (GO:0120031). GO:0120031 is a biological process from the Gene Ontology. ↑ INCREASED TNT-shielded escape from maternal type III interferon control GO:0042783 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves increased TNT-shielded escape from maternal type III interferon control, annotated with symbiont-mediated evasion of host immune response (GO:0042783). GO:0042783 is a biological process from the Gene Ontology. ↑ INCREASED maternal type III interferon (IFN-lambda) signaling at the maternal-fetal interface GO:0038196 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves maternal type III interferon (IFN-lambda) signaling at the maternal-fetal interface, annotated with type III interferon-mediated signaling pathway (GO:0038196). GO:0038196 is a biological process from the Gene Ontology.
Show evidence (4 references)
PMID:42627154 SUPPORT Model Organism
"We previously showed that ZIKV induces tunneling nanotubes (TNTs), actin-rich intercellular conduits that enable direct cell-to-cell transfer of viral components."
Defines TNTs as actin-rich conduits mediating direct cell-to-cell transfer of ZIKV components.
PMID:42627154 SUPPORT Model Organism
"A TNT-deficient ZIKV mutant (ZIKVΔTNT), harboring a change between residues 40 and 52 of the nonstructural protein 1 (NS1), showed markedly reduced viral dissemination to maternal and fetal tissues across all models tested, whereas the TNT-competent ZIKV established a robust infection."
Loss-of-function genetic evidence that NS1-dependent TNT formation is required for maternal and fetal dissemination.
PMID:42627154 SUPPORT Model Organism
"Loss of TNT-forming capacity also limited viral persistence despite maternal type III interferon (IFN-λ) responses, suggesting a role for TNTs in immune evasion."
Links TNT-mediated spread to viral persistence under an active maternal IFN-lambda response.
+ 1 more reference
Placental Infection
ZIKV productively infects the placenta, producing histological placental pathology. The causal role of viral spread is established by the contrast with the TNT-deficient mutant, which produces less placental pathology. The placenta is therefore not merely a barrier ZIKV crosses but a target organ in its own right.
trophoblast cell CL:0000351 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves trophoblast cell (CL:0000351). CL:0000351 is a cell type from the Cell Ontology.
placenta UBERON:0001987 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in placenta (UBERON:0001987). UBERON:0001987 is an anatomical location from the Uberon multi-species anatomy ontology.
Show evidence (2 references)
PMID:42627154 SUPPORT Model Organism
"Using multiple pregnancy models, we demonstrate that viruses capable of forming these structures disseminate more efficiently, damage the placenta, and lead to fetal growth restriction, whereas TNT-deficient viruses show reduced infection and milder disease."
States directly that TNT-competent virus damages the placenta, across the pregnancy models tested.
PMID:42627154 SUPPORT Model Organism
"ZIKVΔTNT infection was associated with reduced placental pathology, altered junctional-to-labyrinth architecture, improved placental efficiency, and protection from fetal growth restriction."
The reduced placental pathology in the TNT-deficient mutant is the loss-of-function counterpart of the damage claim.
Placental Architectural and Functional Disruption
Infected placentas differ from TNT-deficient-infected controls in the relative architecture of the placental compartments, and in placental efficiency (fetal mass supported per unit placental mass), which improves when viral spread is crippled.
placental architecture and efficiency GO:0001890 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves abnormal placental architecture and efficiency, annotated with placenta development (GO:0001890). GO:0001890 is a biological process from the Gene Ontology. ⚠ ABNORMAL
placenta UBERON:0001987 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in placenta (UBERON:0001987). UBERON:0001987 is an anatomical location from the Uberon multi-species anatomy ontology.
Show evidence (1 reference)
PMID:42627154 SUPPORT Model Organism
"ZIKVΔTNT infection was associated with reduced placental pathology, altered junctional-to-labyrinth architecture, improved placental efficiency, and protection from fetal growth restriction."
Reports the altered compartment architecture and the improved placental efficiency of the TNT-deficient condition.
Fetal Growth Restriction
The most distal outcome of the placental arm in the pregnancy models tested: TNT-competent ZIKV infection leads to fetal growth restriction, while TNT-deficient infection protects against it.
Show evidence (2 references)
PMID:42627154 SUPPORT Model Organism
"ZIKVΔTNT infection was associated with reduced placental pathology, altered junctional-to-labyrinth architecture, improved placental efficiency, and protection from fetal growth restriction."
Protection from fetal growth restriction in the TNT-deficient condition is the loss-of-function evidence for this outcome.
PMID:42627154 SUPPORT Model Organism
"Using multiple pregnancy models, we demonstrate that viruses capable of forming these structures disseminate more efficiently, damage the placenta, and lead to fetal growth restriction, whereas TNT-deficient viruses show reduced infection and milder disease."
States that TNT-competent virus leads to fetal growth restriction across the models tested.
Transplacental Viral Transfer to the Fetal Compartment
Crossing the maternal-fetal interface is a transport step, distinct from what the virus does once it arrives. Human placental work identifies more than one route rather than a single breach: ZIKV productively infects placental macrophages (Hofbauer cells) and, less efficiently, cytotrophoblasts in term villous tissue, and separately infects cytotrophoblasts, endothelial cells, fibroblasts and Hofbauer cells in chorionic villi together with amniotic epithelial cells and trophoblast progenitors in amniochorionic membranes. Those cells express the Axl, Tyro3 and TIM1 entry cofactors, so the same TAM-family biology operates here as in the fetal brain — but on different cells, in a different organ, supporting a different claim. Curating them as one node conflated the two. Transfer is not uniformly permissive, and the restriction side explains the timing dependence the rest of this entry rests on. Primary human trophoblasts from full-term placentas are refractory to ZIKV and constitutively release type III interferon (IFN-lambda1) that protects both trophoblast and non-trophoblast cells, so virus reaching the fetal compartment must evade or bypass that barrier. Consistent with a barrier that strengthens as gestation proceeds, mid-gestation amniotic epithelial cells support higher viral titres than late-gestation cells.
Hofbauer cell (placental macrophage) CL:3000001 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves Hofbauer cell (placental macrophage), annotated with Hofbauer cell (CL:3000001). CL:3000001 is a cell type from the Cell Ontology. Cytotrophoblast CL:0000523 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves Cytotrophoblast, annotated with mononuclear cytotrophoblast cell (CL:0000523). CL:0000523 is a cell type from the Cell Ontology.
type III interferon production by trophoblast GO:0034343 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves type III interferon production by trophoblast, annotated with type III interferon production (GO:0034343). GO:0034343 is a biological process from the Gene Ontology.
placenta UBERON:0001987 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in placenta (UBERON:0001987). UBERON:0001987 is an anatomical location from the Uberon multi-species anatomy ontology.
Show evidence (7 references)
PMID:27247001 SUPPORT In Vitro
"Our results suggest a mechanism for intrauterine transmission in which ZIKV gains access to the fetal compartment by directly infecting placental cells and disrupting the placental barrier."
States the transfer mechanism this node curates, in primary human placental cells rather than in a model organism.
PMID:27247001 SUPPORT In Vitro
"infects and replicates in primary human placental macrophages, called Hofbauer cells, and to a lesser extent in cytotrophoblasts, isolated from villous tissue of full-term placentae"
Identifies the two placental cell types curated on this node, with their relative permissiveness.
PMID:27443522 SUPPORT In Vitro
"Our results suggest that ZIKV spreads from basal and parietal decidua to chorionic villi and amniochorionic membranes and that targeting TIM1 could suppress infection at the uterine-placental interface."
The two-route structure of transfer, and the cofactor that is druggable at the uterine-placental interface specifically.
+ 4 more references
Neurotropic Entry into Fetal Neural Progenitors
Once in the fetal brain, ZIKV is neurotropic for radial glia and neural progenitor cells. Candidate entry receptors enriched on these cells — notably the TAM-family receptor tyrosine kinase AXL, which is highly expressed by human radial glia in the developing cortex — are thought to mediate or facilitate viral attachment and entry, establishing infection of the founder progenitor population during corticogenesis. Neuropathology confirms the target: infection of progenitor cells at the germinal matrix has been demonstrated in human material. AXL appears on both sides of this entry's transfer/entry split, and the duplication is real biology rather than a curation artefact: the same TAM-family cofactors are used at the placenta and on radial glia. They are nonetheless different claims about different cells in different organs, and are curated on the node each belongs to.
Radial glial cell CL:0000681 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves Radial glial cell (CL:0000681). CL:0000681 is a cell type from the Cell Ontology. Neural progenitor cell CL:0011020 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves Neural progenitor cell (CL:0011020). CL:0011020 is a cell type from the Cell Ontology.
Viral entry into host cell GO:0046718 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves increased Viral entry into host cell, annotated with symbiont entry into host cell (GO:0046718). GO:0046718 is a biological process from the Gene Ontology. ↑ INCREASED Viral genome replication GO:0019079 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves increased Viral genome replication (GO:0019079). GO:0019079 is a biological process from the Gene Ontology. ↑ INCREASED
Show evidence (2 references)
PMID:27038591 SUPPORT In Vitro
"we found that the candidate viral entry receptor AXL is highly expressed by human radial glial cells, astrocytes, endothelial cells, and microglia in developing human cortex and by progenitor cells in developing retina."
Identifies AXL on human radial glia as a candidate entry receptor enriched on the progenitor population ZIKV targets.
PMID:29167994 SUPPORT Human Clinical
"Infection of progenitor cells at the germinal matrix was demonstrated."
Human neuropathological confirmation that the progenitor population is the infected compartment, rather than this resting on culture systems alone.
Spinal Anterior Horn Motor Neuron Loss
Severe motor nerve cell loss in the anterior horn of the spinal cord is a consistent postmortem finding in congenital ZIKV infection, alongside hypoplasia of the descending tracts (small basis pontis, pyramids and spinal corticospinal tracts) that follows the loss of cortical output. The anterior horn lesion is the one that matters here, because it is what connects this entry's cortical mechanism to a phenotype the cortex cannot explain.
Anterior horn motor neuron CL:2000048 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves Anterior horn motor neuron (CL:2000048). CL:2000048 is a cell type from the Cell Ontology.
ventral horn of spinal cord UBERON:0002257 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in ventral horn of spinal cord (UBERON:0002257). UBERON:0002257 is an anatomical location from the Uberon multi-species anatomy ontology.
Show evidence (2 references)
PMID:29167994 SUPPORT Human Clinical
"Severe nerve motor nerve cell loss is observed in the anterior horn of the spinal cord."
The anterior horn lesion, in human postmortem material. Quoted as written, including the source's duplicated word.
PMID:29167994 SUPPORT Human Clinical
"Hypoplastic lesions secondary to the lack of descending nerve fibers include small basis pontis, pyramids and spinal corticospinal tracts."
The separate, secondary tract hypoplasia that follows cortical loss, kept distinct from the primary anterior horn lesion above.
Fetal Akinesia
Absent or greatly reduced fetal movement, the consequence of losing spinal motor neurons. This node exists because the resulting arthrogryposis is neurogenic rather than articular, and the distinction is testable: in the reported series, high-definition ultrasonography of the joints showed no abnormality, while needle electromyography showed motor unit remodeling and reduced recruitment, and spinal MRI showed apparent cord thinning with reduced ventral roots. The joints are normal; the nerves supplying them are not.
Show evidence (3 references)
PMID:29167994 SUPPORT Human Clinical
"The lack of spinal motor neurons is responsible for fetal acynesia and consequent arthrogryposis."
The causal claim this node and its downstream edge encode, stated by the source. The source's spelling of akinesia is preserved in the quote.
PMID:27509902 SUPPORT Human Clinical
"All the children underwent high definition ultrasonography of the joints, and there was no evidence of abnormalities."
The negative joint imaging that excludes a primary articular cause and so makes the neurogenic account load-bearing rather than assumed.
PMID:27509902 SUPPORT Human Clinical
"MRI of the spine in four children showed apparent thinning of the cord and reduced ventral roots."
Imaging correlate of the anterior horn lesion in living patients, matching the postmortem finding.
Antiviral Innate Immune Activation
ZIKV infection activates innate antiviral signalling within developing neural progenitor systems. Human cerebral organoid and neurosphere data implicate Toll-like receptor 3 (TLR3) activation and type I interferon-linked responses in perturbed neurogenesis, altered cell fate, and downstream progenitor loss; TLR3 inhibition mitigates the phenotype in experimental models.
Neural progenitor cell CL:0011020 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves Neural progenitor cell (CL:0011020). CL:0011020 is a cell type from the Cell Ontology. Radial glial cell CL:0000681 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves Radial glial cell (CL:0000681). CL:0000681 is a cell type from the Cell Ontology.
Innate immune response GO:0045087 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves increased Innate immune response (GO:0045087). GO:0045087 is a biological process from the Gene Ontology. ↑ INCREASED Toll-like receptor signaling pathway GO:0002224 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves increased Toll-like receptor signaling pathway (GO:0002224). GO:0002224 is a biological process from the Gene Ontology. ↑ INCREASED Type I interferon-mediated signaling pathway GO:0060337 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves dysregulated Type I interferon-mediated signaling pathway (GO:0060337). GO:0060337 is a biological process from the Gene Ontology. ↕ DYSREGULATED Defense response to virus GO:0051607 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves dysregulated Defense response to virus (GO:0051607). GO:0051607 is a biological process from the Gene Ontology. ↕ DYSREGULATED
Show evidence (2 references)
PMID:27162029 SUPPORT In Vitro
"The innate immune receptor Toll-like-Receptor 3 (TLR3) was upregulated after ZIKV infection of human organoids and mouse neurospheres and TLR3 inhibition reduced the phenotypic effects of ZIKV infection."
Implicates TLR3 innate immune activation in ZIKV-driven progenitor cytopathy, with inhibition reducing the experimental phenotype.
PMID:27162029 SUPPORT In Vitro
"Together, therefore, our findings identify a link between ZIKV-mediated TLR3 activation, perturbed cell fate, and a reduction in organoid volume reminiscent of microcephaly."
Connects ZIKV-triggered TLR3 activation to perturbed cell fate and reduced organoid volume in a human cerebral organoid model.
Viral Mitotic and Centrosome Cytopathy
ZIKV productively infects human neural progenitor cells and radial glia, releasing infectious virus and perturbing cell-cycle progression, mitotic machinery, centrosome integrity, and phospho-TBK1 localization. These mitotic and centrosome defects impair proliferative progenitor divisions and converge on the same neural progenitor centrosome/spindle dysfunction module used by genetic cortical malformation entries.
Neural progenitor cell CL:0011020 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves Neural progenitor cell (CL:0011020). CL:0011020 is a cell type from the Cell Ontology. Radial glial cell CL:0000681 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves Radial glial cell (CL:0000681). CL:0000681 is a cell type from the Cell Ontology.
Mitotic cell cycle GO:0000278 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves dysregulated Mitotic cell cycle (GO:0000278). GO:0000278 is a biological process from the Gene Ontology. ↕ DYSREGULATED Cell cycle GO:0007049 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves dysregulated Cell cycle (GO:0007049). GO:0007049 is a biological process from the Gene Ontology. ↕ DYSREGULATED Mitotic spindle organization GO:0007052 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves dysregulated Mitotic spindle organization (GO:0007052). GO:0007052 is a biological process from the Gene Ontology. ↕ DYSREGULATED Centrosome cycle GO:0007098 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves abnormal Centrosome cycle (GO:0007098). GO:0007098 is a biological process from the Gene Ontology. ⚠ ABNORMAL
Show evidence (3 references)
PMID:26952870 SUPPORT In Vitro
"ZIKV infection increases cell death and dysregulates cell-cycle progression, resulting in attenuated hNPC growth."
Links infection to cell-cycle dysregulation and attenuated progenitor growth.
PMID:27568284 SUPPORT In Vitro
"ZIKV infection of NES cells and RGCs causes centrosomal depletion and mitochondrial sequestration of phospho-TBK1 during mitosis."
Supports mitotic centrosome/TBK1 cytopathy in infected human neuroepithelial stem cells and radial glia.
PMID:28132835 SUPPORT In Vitro
"The main phenotypic effect was premature differentiation of neural progenitors associated with centrosome perturbation, even during early stages of infection, leading to progenitor depletion, disruption of the VZ, impaired neurogenesis, and cortical thinning."
Human brain organoids show ZIKV-associated centrosome perturbation leading to progenitor depletion and cortical thinning.
Neural Progenitor Apoptosis and Pool Depletion
Innate antiviral activation, viral replication, cell-cycle disruption, and mitotic/centrosome stress converge on caspase-mediated apoptosis, autophagy, premature differentiation, and reduced viability of neural progenitors and radial glia. The founder progenitor pool is depleted, leaving too few neuron-generating cells for normal cortical expansion.
Neural progenitor cell CL:0011020 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves Neural progenitor cell (CL:0011020). CL:0011020 is a cell type from the Cell Ontology. Radial glial cell CL:0000681 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves Radial glial cell (CL:0000681). CL:0000681 is a cell type from the Cell Ontology.
Apoptotic process GO:0006915 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves increased Apoptotic process (GO:0006915). GO:0006915 is a biological process from the Gene Ontology. ↑ INCREASED Neurogenesis GO:0022008 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased Neurogenesis (GO:0022008). GO:0022008 is a biological process from the Gene Ontology. ↓ DECREASED Cell population proliferation GO:0008283 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased Cell population proliferation (GO:0008283). GO:0008283 is a biological process from the Gene Ontology. ↓ DECREASED
Show evidence (3 references)
PMID:27064148 SUPPORT In Vitro
"we showed that ZIKV targets human brain cells, reducing their viability and growth as neurospheres and brain organoids. These results suggest that ZIKV abrogates neurogenesis during human brain development."
Demonstrates that ZIKV reduces human neural progenitor viability/growth and abrogates neurogenesis.
PMID:26952870 SUPPORT In Vitro
"ZIKV infection increases cell death and dysregulates cell-cycle progression, resulting in attenuated hNPC growth."
Connects infection-driven cell death and cell-cycle dysregulation to reduced progenitor growth.
PMID:27279226 SUPPORT Model Organism
"ZIKV(BR) crosses the placenta and causes microcephaly by targeting cortical progenitor cells, inducing cell death by apoptosis and autophagy, and impairing neurodevelopment."
Establishes apoptosis and autophagy of cortical progenitors as in vivo mechanisms of ZIKV-induced microcephaly.
Impaired Neurogenesis and Congenital Cortical Malformation
Depletion of the cortical progenitor pool and impaired neurogenesis reduce the complement of cortical neurons, producing severe microcephaly with a disproportionately small brain. Unlike many genetic microcephalies, the CZS cortex shows a more destructive pathology, with near-complete agyria (lissencephaly-like smoothing), multifocal cortical and subcortical calcifications, hydrocephalus/ventriculomegaly, and cortical displacement, reflecting prominent cell death during development.
Neural progenitor cell CL:0011020 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves Neural progenitor cell (CL:0011020). CL:0011020 is a cell type from the Cell Ontology.
Neurogenesis GO:0022008 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased Neurogenesis (GO:0022008). GO:0022008 is a biological process from the Gene Ontology. ↓ DECREASED Cerebral cortex development GO:0021987 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves abnormal Cerebral cortex development (GO:0021987). GO:0021987 is a biological process from the Gene Ontology. ⚠ ABNORMAL
Show evidence (2 references)
PMID:26862926 SUPPORT Human Clinical
"Micrencephaly (an abnormally small brain) was observed, with almost complete agyria, hydrocephalus, and multifocal dystrophic calcifications in the cortex and subcortical white matter, with associated cortical displacement and mild focal inflammation."
Human fetal autopsy documenting the destructive cortical malformation phenotype of CZS.
PMID:27179424 SUPPORT Model Organism
"ZIKV infection leads to cell-cycle arrest, apoptosis, and inhibition of NPC differentiation, resulting in cortical thinning and microcephaly."
In vivo recapitulation of cortical thinning and microcephaly as the developmental endpoint.

Histopathology

1
Destructive cortical injury with calcification and migration disturbance
The postmortem picture is destructive rather than purely hypoplastic, which is what distinguishes CZS from genetic primary microcephaly on tissue. It combines extensive parenchymal destruction, calcification, disturbed neuronal migration, and a reactive glial and microglial response, with occasional perivascular lymphocytic cuffing extending to the meninges.
Show evidence (1 reference)
PMID:29167994 SUPPORT Human Clinical
"there is extensive destruction of the hemispheric parenchyma, calcifications, various disturbances of neuronal migration, reactive gliosis, microglial hyperplasia and occasional perivascular cuffs of lymphocytes, also in the meninges"
The full histological description, including the inflammatory component that a purely developmental account would not predict.

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.
Pathograph: causal mechanism network for Congenital Zika Syndrome Interactive directed graph showing how pathophysiology mechanisms, phenotypes, genetic factors and variants, experimental models, environmental triggers, and treatments relate through causal and linked edges.

Phenotypes

14
Digestive 1
Dysphagia FREQUENT HP:0002015 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Dysphagia (HP:0002015). HP:0002015 is a phenotype from the Human Phenotype Ontology.
Show evidence (3 references)
PMID:41460891 SUPPORT Human Clinical
"In the pooled analyses, dysphagia was common and observed in 46.9% of children."
Pooled frequency across 12 cohorts, the basis for the FREQUENT band.
PMID:27509902 SUPPORT Human Clinical
"Dysphagia was present in six children (86%); two underwent gastrostomy and tracheostomy."
Much higher frequency in the arthrogryposis series, consistent with dysphagia tracking overall neurological severity rather than being an independent feature.
PMID:33320867 SUPPORT Human Clinical
"Dysphagia can increase the risk of bronchoaspiration, resulting in aspiration pneumonia or death from asphyxiation, requiring gastrostomy in the affected infants"
States the mechanism by which dysphagia becomes fatal, which is why it is curated as a phenotype in its own right rather than folded into feeding difficulty.
Ear 1
Sensorineural Hearing Loss OCCASIONAL Sensorineural hearing impairment HP:0000407 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Sensorineural hearing impairment (HP:0000407). HP:0000407 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:27585248 SUPPORT Human Clinical
"Five (7%) infants had sensorineural hearing loss, all of whom had severe microcephaly"
The frequency in an infant series ascertained on microcephaly, and the observation that every affected infant was severely microcephalic.
PMID:30252119 NO_EVIDENCE Human Clinical
"None of the patients evaluated in this study were found to have sensorineural hearing loss."
Cited to record a negative cohort result, graded NO_EVIDENCE rather than REFUTE because this cohort was ZIKV-exposed rather than CZS-affected: it does not bear on whether hearing loss occurs in congenital Zika syndrome, only on how often it is found when microcephaly is not the entry criterion.
Head and Neck 1
Microcephaly HP:0000252 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Microcephaly (HP:0000252). HP:0000252 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:26862926 SUPPORT Human Clinical
"Micrencephaly (an abnormally small brain) was observed, with almost complete agyria, hydrocephalus, and multifocal dystrophic calcifications in the cortex and subcortical white matter, with associated cortical displacement and mild focal inflammation."
Documents micrencephaly (abnormally small brain) on human fetal autopsy.
Musculoskeletal 1
Spastic Hypertonia VERY_FREQUENT HP:0001276 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Hypertonia (HP:0001276), qualified as course progressive. HP:0001276 is a phenotype from the Human Phenotype Ontology.
Course: PROGRESSIVE
Show evidence (3 references)
PMID:41460891 SUPPORT Human Clinical
"Spastic hypertonia was found in seven sites in which they were investigated, with a frequency of 100% in four sites"
Frequency across the cohorts that assessed it; near-universal where ascertained, which is the basis for the VERY_FREQUENT band.
PMID:41460891 SUPPORT Human Clinical
"spastic hypertonia (at >3 months of age), osteotendinous hyperreflexia"
Records the case definition used, including the age threshold, which is why this is not curated as a congenital finding.
PMID:33320867 SUPPORT Human Clinical
"hydrocephalus, hypertonicity, and seizures; (b) in the osteoskeletal system: arthrogryposis and clubfoot"
Independent corroboration from a systematic review of 46 studies, listing hypertonicity among the defining central nervous system signs.
Nervous System 5
Hydrocephalus HP:0000238 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Hydrocephalus (HP:0000238). HP:0000238 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:26862926 SUPPORT Human Clinical
"almost complete agyria, hydrocephalus, and multifocal dystrophic calcifications"
Records hydrocephalus in the affected fetal brain.
Cerebellar Hypoplasia HP:0001321 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Cerebellar hypoplasia (HP:0001321). HP:0001321 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:29167994 SUPPORT Human Clinical
"Cerebellar hypoplasia is also common."
Records cerebellar involvement as a common postmortem finding.
Ventriculomegaly VERY_FREQUENT HP:0002119 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Ventriculomegaly (HP:0002119). HP:0002119 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:29167994 SUPPORT Human Clinical
"microcephaly with ex-vacuo ventriculomegaly and large head circumference associated with obstructive hydrocephalus due to severe midbrain and aqueduct distortion"
Distinguishes the two mechanisms of ventricular enlargement and records that one of them presents with a large head.
PMID:41460891 SUPPORT Human Clinical
"Calcifications and ventriculomegaly were the most consistent and frequent abnormality (around 80%)."
Pooled frequency across 12 Brazilian cohorts, which is the basis for the VERY_FREQUENT band on this phenotype.
Seizures FREQUENT HP:0001250 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Seizure (HP:0001250), qualified as infantile onset. HP:0001250 is a phenotype from the Human Phenotype Ontology.
Onset: INFANTILE
Show evidence (5 references)
PMID:41460891 SUPPORT Human Clinical
"Epilepsy ranged from 30-80% of the children and dysphagia, from 22.2-67.7%."
Pooled range across 12 Brazilian cohorts of children with Zika-related microcephaly; the spread is the basis for the FREQUENT rather than VERY_FREQUENT band.
PMID:32065676 SUPPORT Human Clinical
"Seizures typically began after the third month of life, usually as infantile spasms, with atypical electroencephalographic abnormalities."
Establishes the timing and semiology, which is why onset is curated as infantile rather than neonatal.
PMID:32065676 SUPPORT Human Clinical
"the main type of seizure was infantile spasms (83.1%)"
Infantile spasms as the predominant seizure type in a 91-child cohort followed for 24 months.
+ 2 more references
Global Developmental Delay HP:0001263 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Global developmental delay (HP:0001263). HP:0001263 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:39082517 SUPPORT Human Clinical
"Eighty-nine children with CZS and cerebral palsy undergoing rehabilitation showed evidence of severe developmental delays at the age of 1 year, according to the Bayley Scale of Infant and Toddler Development III (BSID-III)"
Formal developmental assessment in a CZS cohort, establishing severity. The cohort is selected (children already in rehabilitation for cerebral palsy), which is why it supports the phenotype but not a frequency band.
Growth 1
Small for Gestational Age HP:0001518 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Small for gestational age (HP:0001518). HP:0001518 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:33320867 SUPPORT Human Clinical
"abnormal visual function and low birthweight for gestational age"
Low birthweight for gestational age among the defining features in the systematic review.
Other 4
Lissencephaly HP:0001339 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Lissencephaly (HP:0001339). HP:0001339 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:26862926 SUPPORT Human Clinical
"almost complete agyria, hydrocephalus, and multifocal dystrophic calcifications in the cortex and subcortical white matter"
Records almost complete agyria (lissencephaly-like) in the affected fetal brain.
Intracranial Calcification VERY_FREQUENT Cerebral calcification HP:0002514 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Cerebral calcification (HP:0002514). HP:0002514 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:26862926 SUPPORT Human Clinical
"multifocal dystrophic calcifications in the cortex and subcortical white matter"
Documents the characteristic cortical and subcortical calcifications of CZS.
PMID:41460891 SUPPORT Human Clinical
"Calcifications and ventriculomegaly were the most consistent and frequent abnormality (around 80%)."
Pooled frequency across 12 Brazilian cohorts, which is the basis for the VERY_FREQUENT band on this phenotype.
Arthrogryposis Arthrogryposis multiplex congenita HP:0002804 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Arthrogryposis multiplex congenita (HP:0002804). HP:0002804 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:27509902 SUPPORT Human Clinical
"Arthrogryposis was present in the arms and legs of six children (86%) and the legs of one child (14%)."
Distribution and frequency of contractures within the series.
PMID:29167994 SUPPORT Human Clinical
"Babies with severe brain lesions are born with arthrogryposis."
Independent neuropathological confirmation, and the association with lesion severity.
Chorioretinal Abnormalities Chorioretinal atrophy HP:0000533 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Chorioretinal atrophy (HP:0000533). HP:0000533 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:33320867 SUPPORT Human Clinical
"ocular findings in the posterior and anterior segments, abnormal visual function and low birthweight for gestational age"
Establishes ocular involvement across both segments as a defining feature in a systematic review of 46 studies.
PMID:32920998 SUPPORT Human Clinical
"On follow up of 280 asymptomatic infants, 2/155 (1.3%) had eye abnormalities"
Eye abnormalities in infants who appeared unaffected at birth, which is why ophthalmological screening is recommended irrespective of head size.
💊

Medical Actions

2
Supportive Care
Action: Supportive CareNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is Supportive Care (NCIT:C15747). NCIT:C15747 is a clinical intervention from the NCI Thesaurus. NCIT:C15747
There is no specific antiviral therapy for congenital Zika syndrome. Management is supportive and multidisciplinary, addressing feeding difficulties, seizures, spasticity, and developmental needs.
Physical and Developmental Therapy
Action: physical therapyNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is physical therapy (NCIT:C15302). NCIT:C15302 is a clinical intervention from the NCI Thesaurus. Ontology label: Physical Therapy NCIT:C15302
Early rehabilitative and developmental therapy to support motor function and mitigate the consequences of arthrogryposis and spasticity.
🔬

Diagnosis

2
Maternal gestational age at infection as the dominant risk determinant
Timing of maternal infection is the single strongest predictor of fetal outcome, and is the reason this entry treats first-trimester exposure as the high-risk window rather than as a stylistic emphasis. Neuropathology agrees with the epidemiology: lesion severity tracks gestational age at infection.
Show evidence (2 references)
PMID:32920998 SUPPORT Human Clinical
"Fetal abnormalities were 14.0 (95% CI 7.6-26.0) times more likely with gestational infection occurring in ≤11 weeks."
Quantifies the timing dependence with an effect size and interval.
PMID:29167994 SUPPORT Human Clinical
"The severity of the lesions is directly related to the gestational age, the most severe occurring when the mother is infected in the first trimester."
Independent pathological confirmation of the same gradient, from tissue rather than from outcome statistics.
Screening of apparently unaffected exposed infants
A normal examination at birth does not exclude CZS-spectrum injury. In follow-up of infants classified as asymptomatic, a small proportion had eye abnormalities or CNS imaging findings and a larger proportion had neurological alert signs by three months. Hearing testing is likewise recommended for all infants born to women with evidence of ZIKV infection, including those who appear normal at birth.
Show evidence (2 references)
PMID:32920998 SUPPORT Human Clinical
"On follow up of 280 asymptomatic infants, 2/155 (1.3%) had eye abnormalities, 1/207 (0.5%) had CNS imaging findings and 16/199 (8%) presented neurological alert signs."
Subclinical findings in infants who appeared unaffected, with denominators.
PMID:27585248 SUPPORT Human Clinical
"all infants born to women with evidence of Zika virus infection during pregnancy should have their hearing tested, including infants who appear normal at birth"
The screening recommendation that follows from ascertainment-dependent detection.
📊

Prevalence

2
Symptomatic ZIKV-infected pregnant women, Brazil (Ribeirao Preto region)
Point Prevalence 2500.0 per 100,000 >1 in 1,000
Major signs of congenital Zika syndrome in 13 of 513 fetuses (2.5%) of symptomatic ZIKV-infected women in a prospective population-based cohort. This is a risk per infected pregnancy, not a population prevalence of the disease, and it is conditioned on the mother being symptomatic.
Show evidence (1 reference)
PMID:32920998 SUPPORT Human Clinical
"Of these, 13 (2.5%; 95% CI 1.5-4.3) presented with major signs of congenital Zika syndrome (CZS)."
The proportion with major CZS signs, with its confidence interval.
Liveborn infants of symptomatic ZIKV-infected women, Brazil
Birth Prevalence 3900.0 per 100,000 >1 in 1,000
Microcephaly or other CNS malformation in 19 of 489 liveborn infants (3.9%). Pregnancy losses occurred separately in 4.7% of the cohort, so the liveborn denominator understates total adverse outcomes.
Show evidence (1 reference)
PMID:32920998 SUPPORT Human Clinical
"Microcephaly or other CNS malformations were diagnosed in 1/4 (25.0%) stillbirths and in 19/489 (3.9%; 95% CI 2.5-5.9) of the liveborn infants."
Birth prevalence among liveborn infants, alongside the stillbirth figure.
🔀

Differential Diagnoses

2

Conditions with similar clinical presentations that must be differentiated from Congenital Zika Syndrome:

Other congenital (TORCH) infections
Overlapping Features Congenital cytomegalovirus and toxoplasmosis produce overlapping intracranial calcification, microcephaly, chorioretinal disease and hearing loss, and are the principal differential. The pattern of calcification and the presence of arthrogryposis help, but neither is decisive, so discrimination rests on laboratory confirmation of the agent rather than on imaging phenotype.
Distinguishing Features
  • Arthrogryposis with normal joints and neurogenic electromyographic findings is characteristic of CZS and is not a usual feature of congenital CMV or toxoplasmosis.
  • Sensorineural hearing loss occurs in CZS at a frequency similar to that seen with other congenital viral infections, so it does not discriminate between them.
Show evidence (1 reference)
PMID:27585248 SUPPORT Human Clinical
"which is similar to that seen in association with other congenital viral infections"
States that the hearing-loss frequency does not separate CZS from the other congenital infections, which is why it is listed as a non-discriminating feature.
Genetic primary microcephaly
Overlapping Features Autosomal recessive primary microcephaly converges on the same progenitor-depletion endpoint but differs pathologically: CZS is a destructive process with prominent cell death, necrosis and calcification, whereas genetic primary microcephaly is hypoplastic without those features. The distinction is made on tissue and imaging rather than on head circumference.
Distinguishing Features
  • Calcification, parenchymal destruction and perivascular inflammation favour congenital infection over a germline progenitor defect.
Show evidence (1 reference)
PMID:29167994 SUPPORT Human Clinical
"there is extensive destruction of the hemispheric parenchyma, calcifications, various disturbances of neuronal migration, reactive gliosis, microglial hyperplasia"
The destructive, inflammatory signature that separates CZS from hypoplastic genetic microcephaly on histology.
📊

Related Datasets

3
Human Otic progenitor cell models of congenital hearing loss applied to to Zika virus and cytomegalovirus infections geo:GSE234062
Congenital hearing loss is a common chronic condition affecting children in both developed and developing nations. In many cases, congenital hearing loss is ultimately attributed to viral infection, most often by cytomegalovirus (CMV), but also in Congenital Zika Syndrome (CZS). The mechanisms by which CMV and ZIKV virus cause these cranial developmental defects have not been elucidated. Inner ear development has been particularly difficult to study, given the inaccessibility and scarcity of the tissue in animal models or on human autopsy; however, it is now possible to culture stem-cell derived otic progenitor cells (OPCs).
human BULK RNA SEQ n=36
PMID:38440980
Identified by GEO DataSets index search for Congenital Zika Syndrome (scripts/discover_datasets.py); accession and metadata verified against NCBI E-utilities on 2026-08-01. Title, sample count, and organism are GEO's own values.
RNA-seq of hiPSCs-derived NPCs from 3 pairs of dizygotic discordant twins for Congenital Zika syndrome geo:GSE102128
Congenital Zika syndrome (CZS), caused by Zika virus (ZIKV) infection, has been associated to impairment of early brain development, particularly related to neural progenitor cells (NPCs) survival and growth. In this work we report in a high-throughput manner (RNA-Seq) the differences in the transcriptomes of hiPSCs(human induced pluripotent stem cells)-derived NPCs from 3 pairs of discordant twins for Congenital Zika syndrome (CZS).
human BULK RNA SEQ n=6
PMID:29396410
Identified by GEO DataSets index search for Congenital Zika Syndrome (scripts/discover_datasets.py); accession and metadata verified against NCBI E-utilities on 2026-08-01. Title, sample count, and organism are GEO's own values.
Transcriptomics analysis of trimester-specific full-term placentas from three Zika virus-infected women geo:GSE139181
Effects of Zika virus (ZIKV) infection on placental development during pregnancy are unclear. In this study, full-term placentas from three women, each infected with ZIKV during specific pregnancy trimesters, were harvested for anatomic, immunologic and transcriptomic analysis. Each woman exhibited a unique immune response with raised IL-1RA, IP-10, EGF and RANTES expression, and neutrophil numbers during the acute infection phase. Although ZIKV NS3 antigens co-localized to placental Hofbauer cells, the placentas showed no anatomical defects.
human BULK RNA SEQ n=33
PMID:31709049
Identified by GEO DataSets index search for Congenital Zika Syndrome (scripts/discover_datasets.py); accession and metadata verified against NCBI E-utilities on 2026-08-01. Title, sample count, and organism are GEO's own values.
🐁

Animal Models

1
Dengue-immune cynomolgus macaque ZIKV pregnancy model
A nonhuman primate model of vertical transmission on a developmental timeline close to the human one, used to ask why some ZIKV-exposed fetuses are severely affected and others are not. Its answer is a maternal immunological one that this entry otherwise has no account of: prior dengue immunity worsens fetal outcome.
Species
Cynomolgus macaque
Genotype
Wild type, DENV-immune prior to ZIKV challenge
Publication
{ }

Source YAML

click to show
name: Congenital Zika Syndrome
creation_date: "2026-06-10T12:00:00Z"
category: Infectious Disease
disease_term:
  preferred_term: Zika virus congenital syndrome
  term:
    id: MONDO:0000890
    label: Zika virus congenital syndrome
parents:
- Microcephaly
synonyms:
- CZS
- congenital Zika virus syndrome
- Zika virus congenital syndrome
- congenital Zika virus infection
notes: >-
  Two things about this entry are worth knowing before extending it.

  First, the risk figures are lower than the outbreak-era coverage implies and
  should not be quoted from memory. In the largest Brazilian prospective cohort,
  major signs of CZS occurred in 2.5% of fetuses of symptomatic ZIKV-infected
  women and microcephaly or other CNS malformation in 3.9% of liveborn infants.
  What is large is not the absolute risk but its dependence on timing: fetal
  abnormalities were 14 times more likely when maternal infection occurred at or
  before 11 weeks.

  Second, head circumference is not a sufficient case definition, and the entry
  is curated so as not to imply that it is. Ventricular enlargement in CZS can be
  obstructive rather than ex-vacuo and present with a LARGE head; eye
  abnormalities and neurological alert signs occur in infants who appear normal
  at birth; and the reported frequency of sensorineural hearing loss depends
  entirely on whether the cohort was ascertained by microcephaly. Each of those
  is curated with the evidence that establishes it rather than left as caveat
  prose.
description: >-
  Congenital Zika syndrome (CZS) is a non-genetic malformation of cortical
  development caused by intrauterine infection with Zika virus (ZIKV), a
  mosquito-borne flavivirus. After maternal infection — most consequential for
  fetal neurodevelopment during the first and second trimesters — ZIKV crosses
  the placenta and reaches the developing fetal central nervous system, where it
  is neurotropic for apical and outer radial glia and other neural progenitor
  cells of the cortical ventricular and subventricular zones. Productive
  infection of these founder progenitors dysregulates the cell cycle, triggers
  caspase-mediated apoptosis, and activates innate antiviral signalling
  (including the TLR3 pathway and type I interferon responses), collectively
  depleting the progenitor pool and abrogating neurogenesis during the peak
  neurogenic window. The resulting deficit of cortical neurons produces the
  recognizable CZS phenotype: severe (often congenital) microcephaly with a
  markedly disproportionate skull, agyria/lissencephaly-like smooth cortex, intracranial
  (cortical and subcortical) calcifications, ventriculomegaly/hydrocephalus,
  and cortical thinning, frequently accompanied by ocular abnormalities,
  arthrogryposis, sensorineural hearing loss, seizures, and global
  developmental delay. CZS is the exemplar infectious (non-Mendelian) cortical
  malformation mechanism: its proximal cause is a defined viral exposure rather
  than a germline variant, but it converges on the same progenitor-depletion
  endpoint as genetic primary microcephaly, distinguished pathologically by a
  more destructive process with prominent cell death, necrosis, and
  calcification.
pathophysiology:
- name: Tunneling Nanotube-Mediated Intercellular Viral Spread
  biological_scale: CELLULAR
  description: >-
    ZIKV induces tunneling nanotubes (TNTs) — actin-rich, membrane-bounded
    intercellular conduits that carry viral components directly from cell to
    cell, bypassing the extracellular space. TNT-forming capacity maps to
    residues 40-52 of the viral nonstructural protein NS1: an engineered
    TNT-deficient mutant (ZIKVΔTNT) disseminates markedly less to maternal
    and fetal tissues than TNT-competent virus across multiple pregnancy models.
    Because transfer through a TNT is shielded from the extracellular
    compartment, this route also appears to let the virus persist in the face of
    a maternal type III interferon (IFN-lambda) response, implicating TNTs in
    immune evasion as well as in spread.
  biological_processes:
  - preferred_term: tunneling nanotube formation
    term:
      id: GO:0120031
      label: plasma membrane bounded cell projection assembly
    modifier: INCREASED
  - preferred_term: TNT-shielded escape from maternal type III interferon control
    term:
      id: GO:0042783
      label: symbiont-mediated evasion of host immune response
    modifier: INCREASED
  - preferred_term: maternal type III interferon (IFN-lambda) signaling at the maternal-fetal interface
    term:
      id: GO:0038196
      label: type III interferon-mediated signaling pathway
  evidence:
  - reference: PMID:42627154
    reference_title: "Tunneling nanotubes contribute to Zika virus pathogenesis at the maternal-fetal interface in vivo."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "We previously showed that ZIKV induces tunneling nanotubes (TNTs), actin-rich intercellular conduits that enable direct cell-to-cell transfer of viral components."
    explanation: Defines TNTs as actin-rich conduits mediating direct cell-to-cell transfer of ZIKV components.
  - reference: PMID:42627154
    reference_title: "Tunneling nanotubes contribute to Zika virus pathogenesis at the maternal-fetal interface in vivo."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "A TNT-deficient ZIKV mutant (ZIKVΔTNT), harboring a change between residues 40 and 52 of the nonstructural protein 1 (NS1), showed markedly reduced viral dissemination to maternal and fetal tissues across all models tested, whereas the TNT-competent ZIKV established a robust infection."
    explanation: Loss-of-function genetic evidence that NS1-dependent TNT formation is required for maternal and fetal dissemination.
  - reference: PMID:42627154
    reference_title: "Tunneling nanotubes contribute to Zika virus pathogenesis at the maternal-fetal interface in vivo."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Loss of TNT-forming capacity also limited viral persistence despite maternal type III interferon (IFN-λ) responses, suggesting a role for TNTs in immune evasion."
    explanation: Links TNT-mediated spread to viral persistence under an active maternal IFN-lambda response.
  - reference: PMID:42627154
    reference_title: "Tunneling nanotubes contribute to Zika virus pathogenesis at the maternal-fetal interface in vivo."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Together, these findings provide in vivo evidence that TNTs are a key mechanism by which ZIKV enhances dissemination, promotes placental dysfunction, and drives fetal pathogenesis."
    explanation: The authors' in vivo summary claim placing TNTs upstream of placental dysfunction and fetal pathology.
  notes: >-
    No ontology term exists for the tunneling nanotube itself in GO, CL, or
    UBERON, so the structure is carried as a free-text `preferred_term` over the
    closest available parent process rather than being force-bound to `cytoneme`
    (GO:0035230) or `intercellular bridge` (GO:0045171), which name different
    structures. Recorded as an OBO gap. All evidence for this node is mouse
    in vivo; TNTs have not been demonstrated in human placental tissue in vivo
    (see the discussions block).
  downstream:
  - target: Placental Infection
    description: >-
      TNT-mediated spread within the placenta drives productive placental
      infection.
  - target: Transplacental Viral Transfer to the Fetal Compartment
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    description: >-
      TNT-competent virus reaches maternal and fetal tissues far more
      efficiently than TNT-deficient virus. The edge is retained because that
      dissemination difference is directly measured, but marked indirect: the
      route to the fetal compartment runs through placental infection, which is
      curated as its own node between the two.
- name: Placental Infection
  biological_scale: TISSUE
  description: >-
    ZIKV productively infects the placenta, producing histological placental
    pathology. The causal role of viral spread is established by the contrast
    with the TNT-deficient mutant, which produces less placental pathology. The
    placenta is therefore not merely a barrier ZIKV crosses but a target organ
    in its own right.
  cell_types:
  - preferred_term: trophoblast cell
    term:
      id: CL:0000351
      label: trophoblast cell
  locations:
  - preferred_term: placenta
    term:
      id: UBERON:0001987
      label: placenta
  evidence:
  - reference: PMID:42627154
    reference_title: "Tunneling nanotubes contribute to Zika virus pathogenesis at the maternal-fetal interface in vivo."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Using multiple pregnancy models, we demonstrate that viruses capable of forming these structures disseminate more efficiently, damage the placenta, and lead to fetal growth restriction, whereas TNT-deficient viruses show reduced infection and milder disease."
    explanation: States directly that TNT-competent virus damages the placenta, across the pregnancy models tested.
  - reference: PMID:42627154
    reference_title: "Tunneling nanotubes contribute to Zika virus pathogenesis at the maternal-fetal interface in vivo."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "ZIKVΔTNT infection was associated with reduced placental pathology, altered junctional-to-labyrinth architecture, improved placental efficiency, and protection from fetal growth restriction."
    explanation: The reduced placental pathology in the TNT-deficient mutant is the loss-of-function counterpart of the damage claim.
  notes: >-
    The trophoblast cell type is not named in PMID:42627154, whose placental
    readouts are the rodent junctional zone and labyrinth; `CL:0000351` is
    supplied from general placental biology as the resident parenchymal cell
    type of the infected organ, not asserted by this reference. All evidence for
    this node is mouse in vivo. No `conforms_to` is declared: the closest
    candidate, `innate_antiviral_interferon_response#Viral Interferon Antagonism
    and Innate Immune Evasion`, is about pathway antagonism (GO:0039502
    symbiont-mediated suppression of interferon signalling), which is a
    different mechanism from the physical compartment-shielding curated here —
    considered and declined rather than overlooked.
  downstream:
  - target: Placental Architectural and Functional Disruption
    description: >-
      Placental infection is followed by change in the relative architecture of
      the placental compartments and a fall in placental efficiency.
  - target: Transplacental Viral Transfer to the Fetal Compartment
    causal_link_type: DIRECT
    description: >-
      Placental infection and barrier injury permit virus to reach the fetal
      compartment and the developing central nervous system.
- name: Placental Architectural and Functional Disruption
  biological_scale: TISSUE
  description: >-
    Infected placentas differ from TNT-deficient-infected controls in the
    relative architecture of the placental compartments, and in placental
    efficiency (fetal mass supported per unit placental mass), which improves
    when viral spread is crippled.
  locations:
  - preferred_term: placenta
    term:
      id: UBERON:0001987
      label: placenta
  biological_processes:
  - preferred_term: placental architecture and efficiency
    term:
      id: GO:0001890
      label: placenta development
    modifier: ABNORMAL
  evidence:
  - reference: PMID:42627154
    reference_title: "Tunneling nanotubes contribute to Zika virus pathogenesis at the maternal-fetal interface in vivo."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "ZIKVΔTNT infection was associated with reduced placental pathology, altered junctional-to-labyrinth architecture, improved placental efficiency, and protection from fetal growth restriction."
    explanation: Reports the altered compartment architecture and the improved placental efficiency of the TNT-deficient condition.
  notes: >-
    CRITICAL species caveat: the junctional zone and labyrinth are compartments
    of the *rodent* placenta and have no direct human homolog, so the measured
    "junctional-to-labyrinth architecture" readout cannot be carried over to
    human placental pathology. All evidence for this node is mouse in vivo.
    Scope of what the source states: the architectural readout is reported as
    *altered* in the TNT-deficient condition, with no direction given, so this
    node makes no claim about which way TNT-competent infection shifts it. The
    efficiency change does have a direction — the mutant improves it — and is
    stated as such in the description.
  downstream:
  - target: Fetal Growth Restriction
    description: >-
      Reduced placental efficiency limits fetal growth; crippling viral spread
      protects against the growth deficit.
- name: Fetal Growth Restriction
  biological_scale: ORGANISM
  description: >-
    The most distal outcome of the placental arm in the pregnancy models tested:
    TNT-competent ZIKV infection leads to fetal growth restriction, while
    TNT-deficient infection protects against it.
  evidence:
  - reference: PMID:42627154
    reference_title: "Tunneling nanotubes contribute to Zika virus pathogenesis at the maternal-fetal interface in vivo."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "ZIKVΔTNT infection was associated with reduced placental pathology, altered junctional-to-labyrinth architecture, improved placental efficiency, and protection from fetal growth restriction."
    explanation: Protection from fetal growth restriction in the TNT-deficient condition is the loss-of-function evidence for this outcome.
  - reference: PMID:42627154
    reference_title: "Tunneling nanotubes contribute to Zika virus pathogenesis at the maternal-fetal interface in vivo."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Using multiple pregnancy models, we demonstrate that viruses capable of forming these structures disseminate more efficiently, damage the placenta, and lead to fetal growth restriction, whereas TNT-deficient viruses show reduced infection and milder disease."
    explanation: States that TNT-competent virus leads to fetal growth restriction across the models tested.
  notes: >-
    Curated as an ORGANISM-scale pathophysiology node carrying MODEL_ORGANISM
    evidence, and deliberately NOT added to `phenotypes:` as a human phenotype:
    the finding is mouse-only, and model-organism evidence should not be the
    sole support for a human phenotype. A human citation would be needed to
    promote it. See the discussions block.
- name: Transplacental Viral Transfer to the Fetal Compartment
  biological_scale: TISSUE
  description: >-
    Crossing the maternal-fetal interface is a transport step, distinct from
    what the virus does once it arrives. Human placental work identifies more
    than one route rather than a single breach: ZIKV productively infects
    placental macrophages (Hofbauer cells) and, less efficiently,
    cytotrophoblasts in term villous tissue, and separately infects
    cytotrophoblasts, endothelial cells, fibroblasts and Hofbauer cells in
    chorionic villi together with amniotic epithelial cells and trophoblast
    progenitors in amniochorionic membranes. Those cells express the Axl, Tyro3
    and TIM1 entry cofactors, so the same TAM-family biology operates here as in
    the fetal brain — but on different cells, in a different organ, supporting a
    different claim. Curating them as one node conflated the two.

    Transfer is not uniformly permissive, and the restriction side explains the
    timing dependence the rest of this entry rests on. Primary human trophoblasts
    from full-term placentas are refractory to ZIKV and constitutively release
    type III interferon (IFN-lambda1) that protects both trophoblast and
    non-trophoblast cells, so virus reaching the fetal compartment must evade or
    bypass that barrier. Consistent with a barrier that strengthens as gestation
    proceeds, mid-gestation amniotic epithelial cells support higher viral titres
    than late-gestation cells.
  cell_types:
  - preferred_term: Hofbauer cell (placental macrophage)
    term:
      id: CL:3000001
      label: Hofbauer cell
  - preferred_term: Cytotrophoblast
    term:
      id: CL:0000523
      label: mononuclear cytotrophoblast cell
  biological_processes:
  - preferred_term: type III interferon production by trophoblast
    term:
      id: GO:0034343
      label: type III interferon production
  locations:
  - preferred_term: placenta
    term:
      id: UBERON:0001987
      label: placenta
  mechanism_confidence: ESTABLISHED
  evidence:
  - reference: PMID:27247001
    reference_title: "Zika Virus Infects Human Placental Macrophages."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "Our results suggest a mechanism for intrauterine transmission in which ZIKV gains access to the fetal compartment by directly infecting placental cells and disrupting the placental barrier."
    explanation: >-
      States the transfer mechanism this node curates, in primary human placental
      cells rather than in a model organism.
  - reference: PMID:27247001
    reference_title: "Zika Virus Infects Human Placental Macrophages."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "infects and replicates in primary human placental macrophages, called Hofbauer cells, and to a lesser extent in cytotrophoblasts, isolated from villous tissue of full-term placentae"
    explanation: Identifies the two placental cell types curated on this node, with their relative permissiveness.
  - reference: PMID:27443522
    reference_title: "Zika Virus Targets Different Primary Human Placental Cells, Suggesting Two Routes for Vertical Transmission."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "Our results suggest that ZIKV spreads from basal and parietal decidua to chorionic villi and amniochorionic membranes and that targeting TIM1 could suppress infection at the uterine-placental interface."
    explanation: >-
      The two-route structure of transfer, and the cofactor that is druggable at
      the uterine-placental interface specifically.
  - reference: PMID:27443522
    reference_title: "Zika Virus Targets Different Primary Human Placental Cells, Suggesting Two Routes for Vertical Transmission."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "ZIKV produced NS3 and E proteins and generated higher viral titers in amniotic epithelial cells from mid-gestation compared to late-gestation placentas."
    explanation: >-
      Gestational-age dependence measured at the placenta, which is the
      mechanistic counterpart of the clinical first-trimester risk.
  - reference: PMID:27066743
    reference_title: "Type III Interferons Produced by Human Placental Trophoblasts Confer Protection against Zika Virus Infection."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "PHT cells constitutively release the type III interferon (IFN) IFNλ1, which functions in both a paracrine and autocrine manner to protect trophoblast and non-trophoblast cells from ZIKV infection."
    explanation: >-
      The restriction arm. Transfer has to defeat a constitutive barrier, which
      is why it is inefficient and gestational-age dependent rather than
      obligate.
  - reference: PMID:26862926
    reference_title: "Zika Virus Associated with Microcephaly."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "ZIKV was found in the fetal brain tissue on reverse-transcriptase-polymerase-chain-reaction (RT-PCR) assay, with consistent findings on electron microscopy."
    explanation: >-
      Human confirmation that the transfer step completes: virus is recovered
      from fetal brain after maternal infection.
  - reference: PMID:27279226
    reference_title: "The Brazilian Zika virus strain causes birth defects in experimental models."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Here we demonstrate that ZIKV(BR) infects fetuses, causing intrauterine growth restriction, including signs of microcephaly, in mice."
    explanation: In vivo evidence that transfer occurs and is sufficient to produce fetal disease.
  downstream:
  - target: Neurotropic Entry into Fetal Neural Progenitors
    causal_link_type: DIRECT
    description: >-
      Virus that has reached the fetal compartment encounters the developing
      cortex, where a separate set of receptors and cell types governs entry.
- name: Neurotropic Entry into Fetal Neural Progenitors
  biological_scale: CELLULAR
  description: >-
    Once in the fetal brain, ZIKV is neurotropic for radial glia and neural
    progenitor cells. Candidate entry receptors enriched on these cells —
    notably the TAM-family receptor tyrosine kinase AXL, which is highly
    expressed by human radial glia in the developing cortex — are thought to
    mediate or facilitate viral attachment and entry, establishing infection of
    the founder progenitor population during corticogenesis. Neuropathology
    confirms the target: infection of progenitor cells at the germinal matrix
    has been demonstrated in human material.

    AXL appears on both sides of this entry's transfer/entry split, and the
    duplication is real biology rather than a curation artefact: the same
    TAM-family cofactors are used at the placenta and on radial glia. They are
    nonetheless different claims about different cells in different organs, and
    are curated on the node each belongs to.
  conforms_to: viral_neural_progenitor_cytopathy#Fetal Brain Viral Exposure and Progenitor Infection
  cell_types:
  - preferred_term: Radial glial cell
    term:
      id: CL:0000681
      label: radial glial cell
  - preferred_term: Neural progenitor cell
    term:
      id: CL:0011020
      label: neural progenitor cell
  biological_processes:
  - preferred_term: Viral entry into host cell
    term:
      id: GO:0046718
      label: symbiont entry into host cell
    modifier: INCREASED
  - preferred_term: Viral genome replication
    term:
      id: GO:0019079
      label: viral genome replication
    modifier: INCREASED
  mechanism_confidence: ESTABLISHED
  evidence:
  - reference: PMID:27038591
    reference_title: "Expression Analysis Highlights AXL as a Candidate Zika Virus Entry Receptor in Neural Stem Cells."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "we found that the candidate viral entry receptor AXL is highly expressed by human radial glial cells, astrocytes, endothelial cells, and microglia in developing human cortex and by progenitor cells in developing retina."
    explanation: Identifies AXL on human radial glia as a candidate entry receptor enriched on the progenitor population ZIKV targets.
  - reference: PMID:29167994
    reference_title: "Congenital Zika virus infection: a neuropathological review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Infection of progenitor cells at the germinal matrix was demonstrated."
    explanation: >-
      Human neuropathological confirmation that the progenitor population is the
      infected compartment, rather than this resting on culture systems alone.
  downstream:
  - target: Antiviral Innate Immune Activation
  - target: Viral Mitotic and Centrosome Cytopathy
  - target: Spinal Anterior Horn Motor Neuron Loss
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Virus in the developing fetal CNS also reaches the spinal cord, where
      anterior horn motor neurons are lost. Whether this reflects the same
      progenitor-directed cytopathy operating at a second site, or direct
      infection of postmitotic motor neurons, is not established by the
      neuropathological material.
- name: Spinal Anterior Horn Motor Neuron Loss
  biological_scale: TISSUE
  description: >-
    Severe motor nerve cell loss in the anterior horn of the spinal cord is a
    consistent postmortem finding in congenital ZIKV infection, alongside
    hypoplasia of the descending tracts (small basis pontis, pyramids and spinal
    corticospinal tracts) that follows the loss of cortical output. The anterior
    horn lesion is the one that matters here, because it is what connects this
    entry's cortical mechanism to a phenotype the cortex cannot explain.
  cell_types:
  - preferred_term: Anterior horn motor neuron
    term:
      id: CL:2000048
      label: anterior horn motor neuron
  locations:
  - preferred_term: ventral horn of spinal cord
    term:
      id: UBERON:0002257
      label: ventral horn of spinal cord
  mechanism_confidence: ESTABLISHED
  evidence:
  - reference: PMID:29167994
    reference_title: "Congenital Zika virus infection: a neuropathological review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Severe nerve motor nerve cell loss is observed in the anterior horn of the spinal cord."
    explanation: >-
      The anterior horn lesion, in human postmortem material. Quoted as written,
      including the source's duplicated word.
  - reference: PMID:29167994
    reference_title: "Congenital Zika virus infection: a neuropathological review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Hypoplastic lesions secondary to the lack of descending nerve fibers include small basis pontis, pyramids and spinal corticospinal tracts."
    explanation: >-
      The separate, secondary tract hypoplasia that follows cortical loss, kept
      distinct from the primary anterior horn lesion above.
  downstream:
  - target: Fetal Akinesia
    causal_link_type: DIRECT
    description: >-
      Loss of the final common motor pathway removes the fetal movement that
      normal joint development depends on.
- name: Fetal Akinesia
  biological_scale: ORGANISM
  description: >-
    Absent or greatly reduced fetal movement, the consequence of losing spinal
    motor neurons. This node exists because the resulting arthrogryposis is
    neurogenic rather than articular, and the distinction is testable: in the
    reported series, high-definition ultrasonography of the joints showed no
    abnormality, while needle electromyography showed motor unit remodeling and
    reduced recruitment, and spinal MRI showed apparent cord thinning with
    reduced ventral roots. The joints are normal; the nerves supplying them are
    not.
  mechanism_confidence: ESTABLISHED
  evidence:
  - reference: PMID:29167994
    reference_title: "Congenital Zika virus infection: a neuropathological review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The lack of spinal motor neurons is responsible for fetal acynesia and consequent arthrogryposis."
    explanation: >-
      The causal claim this node and its downstream edge encode, stated by the
      source. The source's spelling of akinesia is preserved in the quote.
  - reference: PMID:27509902
    reference_title: "Congenital Zika syndrome with arthrogryposis: retrospective case series study."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "All the children underwent high definition ultrasonography of the joints, and there was no evidence of abnormalities."
    explanation: >-
      The negative joint imaging that excludes a primary articular cause and so
      makes the neurogenic account load-bearing rather than assumed.
  - reference: PMID:27509902
    reference_title: "Congenital Zika syndrome with arthrogryposis: retrospective case series study."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "MRI of the spine in four children showed apparent thinning of the cord and reduced ventral roots."
    explanation: >-
      Imaging correlate of the anterior horn lesion in living patients, matching
      the postmortem finding.
- name: Antiviral Innate Immune Activation
  biological_scale: CELLULAR
  description: >-
    ZIKV infection activates innate antiviral signalling within developing
    neural progenitor systems. Human cerebral organoid and neurosphere data
    implicate Toll-like receptor 3 (TLR3) activation and type I interferon-linked
    responses in perturbed neurogenesis, altered cell fate, and downstream
    progenitor loss; TLR3 inhibition mitigates the phenotype in experimental
    models.
  conforms_to: viral_neural_progenitor_cytopathy#Antiviral Innate Immune Activation
  cell_types:
  - preferred_term: Neural progenitor cell
    term:
      id: CL:0011020
      label: neural progenitor cell
  - preferred_term: Radial glial cell
    term:
      id: CL:0000681
      label: radial glial cell
  biological_processes:
  - preferred_term: Innate immune response
    term:
      id: GO:0045087
      label: innate immune response
    modifier: INCREASED
  - preferred_term: Toll-like receptor signaling pathway
    term:
      id: GO:0002224
      label: toll-like receptor signaling pathway
    modifier: INCREASED
  - preferred_term: Type I interferon-mediated signaling pathway
    term:
      id: GO:0060337
      label: type I interferon-mediated signaling pathway
    modifier: DYSREGULATED
  - preferred_term: Defense response to virus
    term:
      id: GO:0051607
      label: defense response to virus
    modifier: DYSREGULATED
  evidence:
  - reference: PMID:27162029
    reference_title: "Zika Virus Depletes Neural Progenitors in Human Cerebral Organoids through Activation of the Innate Immune Receptor TLR3."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "The innate immune receptor Toll-like-Receptor 3 (TLR3) was upregulated after ZIKV infection of human organoids and mouse neurospheres and TLR3 inhibition reduced the phenotypic effects of ZIKV infection."
    explanation: Implicates TLR3 innate immune activation in ZIKV-driven progenitor cytopathy, with inhibition reducing the experimental phenotype.
  - reference: PMID:27162029
    reference_title: "Zika Virus Depletes Neural Progenitors in Human Cerebral Organoids through Activation of the Innate Immune Receptor TLR3."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "Together, therefore, our findings identify a link between ZIKV-mediated TLR3 activation, perturbed cell fate, and a reduction in organoid volume reminiscent of microcephaly."
    explanation: Connects ZIKV-triggered TLR3 activation to perturbed cell fate and reduced organoid volume in a human cerebral organoid model.
  downstream:
  - target: Neural Progenitor Apoptosis and Pool Depletion
- name: Viral Mitotic and Centrosome Cytopathy
  biological_scale: CELLULAR
  description: >-
    ZIKV productively infects human neural progenitor cells and radial glia,
    releasing infectious virus and perturbing cell-cycle progression, mitotic
    machinery, centrosome integrity, and phospho-TBK1 localization. These
    mitotic and centrosome defects impair proliferative progenitor divisions and
    converge on the same neural progenitor centrosome/spindle dysfunction module
    used by genetic cortical malformation entries.
  conforms_to: viral_neural_progenitor_cytopathy#Viral Mitotic and Centrosome Cytopathy
  cell_types:
  - preferred_term: Neural progenitor cell
    term:
      id: CL:0011020
      label: neural progenitor cell
  - preferred_term: Radial glial cell
    term:
      id: CL:0000681
      label: radial glial cell
  biological_processes:
  - preferred_term: Mitotic cell cycle
    term:
      id: GO:0000278
      label: mitotic cell cycle
    modifier: DYSREGULATED
  - preferred_term: Cell cycle
    term:
      id: GO:0007049
      label: cell cycle
    modifier: DYSREGULATED
  - preferred_term: Mitotic spindle organization
    term:
      id: GO:0007052
      label: mitotic spindle organization
    modifier: DYSREGULATED
  - preferred_term: Centrosome cycle
    term:
      id: GO:0007098
      label: centrosome cycle
    modifier: ABNORMAL
  evidence:
  - reference: PMID:26952870
    reference_title: "Zika Virus Infects Human Cortical Neural Progenitors and Attenuates Their Growth."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "ZIKV infection increases cell death and dysregulates cell-cycle progression, resulting in attenuated hNPC growth."
    explanation: Links infection to cell-cycle dysregulation and attenuated progenitor growth.
  - reference: PMID:27568284
    reference_title: "Zika Virus Disrupts Phospho-TBK1 Localization and Mitosis in Human Neuroepithelial Stem Cells and Radial Glia."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "ZIKV infection of NES cells and RGCs causes centrosomal depletion and mitochondrial sequestration of phospho-TBK1 during mitosis."
    explanation: Supports mitotic centrosome/TBK1 cytopathy in infected human neuroepithelial stem cells and radial glia.
  - reference: PMID:28132835
    reference_title: "Recent Zika Virus Isolates Induce Premature Differentiation of Neural Progenitors in Human Brain Organoids."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "The main phenotypic effect was premature differentiation of neural progenitors associated with centrosome perturbation, even during early stages of infection, leading to progenitor depletion, disruption of the VZ, impaired neurogenesis, and cortical thinning."
    explanation: Human brain organoids show ZIKV-associated centrosome perturbation leading to progenitor depletion and cortical thinning.
  downstream:
  - target: Neural Progenitor Apoptosis and Pool Depletion
- name: Neural Progenitor Apoptosis and Pool Depletion
  biological_scale: CELLULAR
  description: >-
    Innate antiviral activation, viral replication, cell-cycle disruption, and
    mitotic/centrosome stress converge on caspase-mediated apoptosis, autophagy,
    premature differentiation, and reduced viability of neural progenitors and
    radial glia. The founder progenitor pool is depleted, leaving too few
    neuron-generating cells for normal cortical expansion.
  conforms_to: viral_neural_progenitor_cytopathy#Neural Progenitor Apoptosis and Pool Depletion
  cell_types:
  - preferred_term: Neural progenitor cell
    term:
      id: CL:0011020
      label: neural progenitor cell
  - preferred_term: Radial glial cell
    term:
      id: CL:0000681
      label: radial glial cell
  biological_processes:
  - preferred_term: Apoptotic process
    term:
      id: GO:0006915
      label: apoptotic process
    modifier: INCREASED
  - preferred_term: Neurogenesis
    term:
      id: GO:0022008
      label: neurogenesis
    modifier: DECREASED
  - preferred_term: Cell population proliferation
    term:
      id: GO:0008283
      label: cell population proliferation
    modifier: DECREASED
  evidence:
  - reference: PMID:27064148
    reference_title: "Zika virus impairs growth in human neurospheres and brain organoids."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "we showed that ZIKV targets human brain cells, reducing their viability and growth as neurospheres and brain organoids. These results suggest that ZIKV abrogates neurogenesis during human brain development."
    explanation: Demonstrates that ZIKV reduces human neural progenitor viability/growth and abrogates neurogenesis.
  - reference: PMID:26952870
    reference_title: "Zika Virus Infects Human Cortical Neural Progenitors and Attenuates Their Growth."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "ZIKV infection increases cell death and dysregulates cell-cycle progression, resulting in attenuated hNPC growth."
    explanation: Connects infection-driven cell death and cell-cycle dysregulation to reduced progenitor growth.
  - reference: PMID:27279226
    reference_title: "The Brazilian Zika virus strain causes birth defects in experimental models."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "ZIKV(BR) crosses the placenta and causes microcephaly by targeting cortical progenitor cells, inducing cell death by apoptosis and autophagy, and impairing neurodevelopment."
    explanation: Establishes apoptosis and autophagy of cortical progenitors as in vivo mechanisms of ZIKV-induced microcephaly.
  downstream:
  - target: Impaired Neurogenesis and Congenital Cortical Malformation
- name: Impaired Neurogenesis and Congenital Cortical Malformation
  biological_scale: TISSUE
  description: >-
    Depletion of the cortical progenitor pool and impaired neurogenesis reduce
    the complement of cortical neurons, producing severe microcephaly with a
    disproportionately small brain. Unlike many genetic microcephalies, the CZS
    cortex shows a more destructive pathology, with near-complete agyria
    (lissencephaly-like smoothing), multifocal cortical and subcortical
    calcifications, hydrocephalus/ventriculomegaly, and cortical displacement,
    reflecting prominent cell death during development.
  conforms_to: viral_neural_progenitor_cytopathy#Impaired Neurogenesis and Congenital Cortical Malformation
  cell_types:
  - preferred_term: Neural progenitor cell
    term:
      id: CL:0011020
      label: neural progenitor cell
  biological_processes:
  - preferred_term: Neurogenesis
    term:
      id: GO:0022008
      label: neurogenesis
    modifier: DECREASED
  - preferred_term: Cerebral cortex development
    term:
      id: GO:0021987
      label: cerebral cortex development
    modifier: ABNORMAL
  evidence:
  - reference: PMID:26862926
    reference_title: "Zika Virus Associated with Microcephaly."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Micrencephaly (an abnormally small brain) was observed, with almost complete agyria, hydrocephalus, and multifocal dystrophic calcifications in the cortex and subcortical white matter, with associated cortical displacement and mild focal inflammation."
    explanation: Human fetal autopsy documenting the destructive cortical malformation phenotype of CZS.
  - reference: PMID:27179424
    reference_title: "Zika Virus Disrupts Neural Progenitor Development and Leads to Microcephaly in Mice."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "ZIKV infection leads to cell-cycle arrest, apoptosis, and inhibition of NPC differentiation, resulting in cortical thinning and microcephaly."
    explanation: In vivo recapitulation of cortical thinning and microcephaly as the developmental endpoint.
phenotypes:
- category: Neurologic
  name: Microcephaly
  diagnostic: true
  description: >-
    Severe, frequently congenital microcephaly with a markedly disproportionate
    skull is the hallmark feature of congenital Zika syndrome.
  phenotype_term:
    preferred_term: Microcephaly
    term:
      id: HP:0000252
      label: Microcephaly
  evidence:
  - reference: PMID:26862926
    reference_title: "Zika Virus Associated with Microcephaly."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Micrencephaly (an abnormally small brain) was observed, with almost complete agyria, hydrocephalus, and multifocal dystrophic calcifications in the cortex and subcortical white matter, with associated cortical displacement and mild focal inflammation."
    explanation: Documents micrencephaly (abnormally small brain) on human fetal autopsy.
- category: Neurologic
  name: Lissencephaly
  description: >-
    Near-complete agyria (a lissencephaly-like smooth cortex) reflects the
    severe disruption of cortical development.
  phenotype_term:
    preferred_term: Lissencephaly
    term:
      id: HP:0001339
      label: Lissencephaly
  evidence:
  - reference: PMID:26862926
    reference_title: "Zika Virus Associated with Microcephaly."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "almost complete agyria, hydrocephalus, and multifocal dystrophic calcifications in the cortex and subcortical white matter"
    explanation: Records almost complete agyria (lissencephaly-like) in the affected fetal brain.
- category: Neurologic
  name: Intracranial Calcification
  frequency: VERY_FREQUENT
  description: >-
    Multifocal calcifications in the cortex and subcortical white matter are a
    characteristic neuroimaging and pathological feature of CZS.
  phenotype_term:
    preferred_term: Cerebral calcification
    term:
      id: HP:0002514
      label: Cerebral calcification
  evidence:
  - reference: PMID:26862926
    reference_title: "Zika Virus Associated with Microcephaly."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "multifocal dystrophic calcifications in the cortex and subcortical white matter"
    explanation: Documents the characteristic cortical and subcortical calcifications of CZS.
  - reference: PMID:41460891
    reference_title: "Characterization of 843 children with Zika-related microcephaly in the first three years of life: An individual participant data meta-analysis of 12 cohorts in the Zika Brazilian Cohorts consortium."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Calcifications and ventriculomegaly were the most consistent and frequent abnormality (around 80%)."
    explanation: >-
      Pooled frequency across 12 Brazilian cohorts, which is the basis for the
      VERY_FREQUENT band on this phenotype.
- category: Neurologic
  name: Hydrocephalus
  description: >-
    Hydrocephalus/ventriculomegaly accompanies the cortical malformation in
    congenital Zika syndrome.
  phenotype_term:
    preferred_term: Hydrocephalus
    term:
      id: HP:0000238
      label: Hydrocephalus
  evidence:
  - reference: PMID:26862926
    reference_title: "Zika Virus Associated with Microcephaly."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "almost complete agyria, hydrocephalus, and multifocal dystrophic calcifications"
    explanation: Records hydrocephalus in the affected fetal brain.
- category: Musculoskeletal
  name: Arthrogryposis
  description: >-
    Congenital joint contractures, present in the arms and legs of six of seven
    children in the defining series and in the legs alone in the seventh, with
    bilateral hip dislocation in all seven. Curated as neurogenic: see the
    Fetal Akinesia node for the joint-imaging and electromyographic evidence
    that separates this from a primary disorder of the joints.
  phenotype_term:
    preferred_term: Arthrogryposis multiplex congenita
    term:
      id: HP:0002804
      label: Arthrogryposis multiplex congenita
  evidence:
  - reference: PMID:27509902
    reference_title: "Congenital Zika syndrome with arthrogryposis: retrospective case series study."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Arthrogryposis was present in the arms and legs of six children (86%) and the legs of one child (14%)."
    explanation: Distribution and frequency of contractures within the series.
  - reference: PMID:29167994
    reference_title: "Congenital Zika virus infection: a neuropathological review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Babies with severe brain lesions are born with arthrogryposis."
    explanation: >-
      Independent neuropathological confirmation, and the association with lesion
      severity.
- category: Auditory
  name: Sensorineural Hearing Loss
  description: >-
    Sensorineural hearing loss in 5 of 70 (7%) infants with microcephaly and
    laboratory evidence of ZIKV infection, or 5.8% (4 of 69) after excluding one
    child tested following ototoxic antibiotic treatment. All affected infants
    had severe microcephaly.

    The frequency is ascertainment-dependent and this entry does not generalise
    it. A separate cohort of ZIKV-exposed children not selected for microcephaly
    found no sensorineural hearing loss over two years. Those results are not in
    conflict: they describe different populations, and the contrast is the reason
    the recommendation is to test hearing in all exposed infants rather than only
    those who look affected.
  phenotype_term:
    preferred_term: Sensorineural hearing impairment
    term:
      id: HP:0000407
      label: Sensorineural hearing impairment
  frequency: OCCASIONAL
  evidence:
  - reference: PMID:27585248
    reference_title: "Hearing Loss in Infants with Microcephaly and Evidence of Congenital Zika Virus Infection - Brazil, November 2015-May 2016."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Five (7%) infants had sensorineural hearing loss, all of whom had severe microcephaly"
    explanation: >-
      The frequency in an infant series ascertained on microcephaly, and the
      observation that every affected infant was severely microcephalic.
  - reference: PMID:30252119
    reference_title: "Zika Virus Infection during Pregnancy and Sensorineural Hearing Loss among Children at 3 and 24 Months Post-Partum."
    supports: NO_EVIDENCE
    evidence_source: HUMAN_CLINICAL
    snippet: "None of the patients evaluated in this study were found to have sensorineural hearing loss."
    explanation: >-
      Cited to record a negative cohort result, graded NO_EVIDENCE rather than
      REFUTE because this cohort was ZIKV-exposed rather than CZS-affected: it
      does not bear on whether hearing loss occurs in congenital Zika syndrome,
      only on how often it is found when microcephaly is not the entry criterion.
- category: Ophthalmologic
  name: Chorioretinal Abnormalities
  description: >-
    Ocular findings involve both the posterior and anterior segments and are
    accompanied by abnormal visual function. They can be the presenting
    abnormality, and were found in a small proportion of infants who were
    otherwise asymptomatic at birth.
  phenotype_term:
    preferred_term: Chorioretinal atrophy
    term:
      id: HP:0000533
      label: Chorioretinal atrophy
  evidence:
  - reference: PMID:33320867
    reference_title: "Congenital Zika syndrome: A systematic review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "ocular findings in the posterior and anterior segments, abnormal visual function and low birthweight for gestational age"
    explanation: >-
      Establishes ocular involvement across both segments as a defining feature
      in a systematic review of 46 studies.
  - reference: PMID:32920998
    reference_title: "Early maternal Zika infection predicts severe neonatal neurological damage: results from the prospective Natural History of Zika Virus Infection in Gestation cohort study."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "On follow up of 280 asymptomatic infants, 2/155 (1.3%) had eye abnormalities"
    explanation: >-
      Eye abnormalities in infants who appeared unaffected at birth, which is why
      ophthalmological screening is recommended irrespective of head size.
- category: Neurologic
  name: Cerebellar Hypoplasia
  phenotype_term:
    preferred_term: Cerebellar hypoplasia
    term:
      id: HP:0001321
      label: Cerebellar hypoplasia
  evidence:
  - reference: PMID:29167994
    reference_title: "Congenital Zika virus infection: a neuropathological review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Cerebellar hypoplasia is also common."
    explanation: Records cerebellar involvement as a common postmortem finding.
- category: Neurologic
  name: Ventriculomegaly
  frequency: VERY_FREQUENT
  description: >-
    Ventriculomegaly in CZS has two distinct causes that the neuropathology
    separates: ex-vacuo enlargement following parenchymal loss, and genuine
    obstructive hydrocephalus from midbrain and aqueduct distortion. The second
    can present with a large rather than small head, which is the reason head
    circumference alone is an unreliable screen.
  phenotype_term:
    preferred_term: Ventriculomegaly
    term:
      id: HP:0002119
      label: Ventriculomegaly
  evidence:
  - reference: PMID:29167994
    reference_title: "Congenital Zika virus infection: a neuropathological review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "microcephaly with ex-vacuo ventriculomegaly and large head circumference associated with obstructive hydrocephalus due to severe midbrain and aqueduct distortion"
    explanation: >-
      Distinguishes the two mechanisms of ventricular enlargement and records
      that one of them presents with a large head.
  - reference: PMID:41460891
    reference_title: "Characterization of 843 children with Zika-related microcephaly in the first three years of life: An individual participant data meta-analysis of 12 cohorts in the Zika Brazilian Cohorts consortium."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Calcifications and ventriculomegaly were the most consistent and frequent abnormality (around 80%)."
    explanation: >-
      Pooled frequency across 12 Brazilian cohorts, which is the basis for the
      VERY_FREQUENT band on this phenotype.
- category: Neurologic
  name: Seizures
  frequency: FREQUENT
  description: >-
    Epilepsy is one of the two dominant post-natal complications of CZS (the
    other is dysphagia) and is a direct clinical consequence of the cortical
    malformation curated at the Impaired Neurogenesis and Congenital Cortical
    Malformation node. Its phenotype is age-structured rather than uniform:
    onset is typically after the third month, most often as infantile spasms,
    with focal epilepsy predominating in the second year. Seizure control is
    poor, which is why this is a driver of long-term care need and not only a
    diagnostic feature.
  phenotype_term:
    preferred_term: Seizure
    term:
      id: HP:0001250
      label: Seizure
    onset:
      onset_category: INFANTILE
  evidence:
  - reference: PMID:41460891
    reference_title: "Characterization of 843 children with Zika-related microcephaly in the first three years of life: An individual participant data meta-analysis of 12 cohorts in the Zika Brazilian Cohorts consortium."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Epilepsy ranged from 30-80% of the children and dysphagia, from 22.2-67.7%."
    explanation: >-
      Pooled range across 12 Brazilian cohorts of children with Zika-related
      microcephaly; the spread is the basis for the FREQUENT rather than
      VERY_FREQUENT band.
  - reference: PMID:32065676
    reference_title: "Early epilepsy in children with Zika-related microcephaly in a cohort in Recife, Brazil: Characteristics, electroencephalographic findings, and treatment response."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Seizures typically began after the third month of life, usually as infantile spasms, with atypical electroencephalographic abnormalities."
    explanation: >-
      Establishes the timing and semiology, which is why onset is curated as
      infantile rather than neonatal.
  - reference: PMID:32065676
    reference_title: "Early epilepsy in children with Zika-related microcephaly in a cohort in Recife, Brazil: Characteristics, electroencephalographic findings, and treatment response."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "the main type of seizure was infantile spasms (83.1%)"
    explanation: >-
      Infantile spasms as the predominant seizure type in a 91-child cohort
      followed for 24 months.
  - reference: PMID:32065676
    reference_title: "Early epilepsy in children with Zika-related microcephaly in a cohort in Recife, Brazil: Characteristics, electroencephalographic findings, and treatment response."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Overall, only 46.1% of the 65 children with epilepsy responded to treatment."
    explanation: >-
      Treatment response, recorded because poor seizure control is what makes
      this phenotype a long-term burden rather than a transient one.
  - reference: PMID:33320867
    reference_title: "Congenital Zika syndrome: A systematic review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "hydrocephalus, hypertonicity, and seizures; (b) in the osteoskeletal system: arthrogryposis and clubfoot"
    explanation: >-
      Independent corroboration from a systematic review of 46 studies, listing
      seizures among the defining central nervous system signs.
- category: Neurologic
  name: Spastic Hypertonia
  frequency: VERY_FREQUENT
  description: >-
    Spastic hypertonia is the motor consequence of the same cortical lesion and
    is the principal contributor to the cerebral-palsy phenotype these children
    carry. It is distinct from the arthrogryposis curated separately: the
    contractures are present at birth and neurogenic in origin, whereas
    hypertonia is assessed after three months of age and progresses.
  phenotype_term:
    preferred_term: Hypertonia
    term:
      id: HP:0001276
      label: Hypertonia
    clinical_course: PROGRESSIVE
  evidence:
  - reference: PMID:41460891
    reference_title: "Characterization of 843 children with Zika-related microcephaly in the first three years of life: An individual participant data meta-analysis of 12 cohorts in the Zika Brazilian Cohorts consortium."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Spastic hypertonia was found in seven sites in which they were investigated, with a frequency of 100% in four sites"
    explanation: >-
      Frequency across the cohorts that assessed it; near-universal where
      ascertained, which is the basis for the VERY_FREQUENT band.
  - reference: PMID:41460891
    reference_title: "Characterization of 843 children with Zika-related microcephaly in the first three years of life: An individual participant data meta-analysis of 12 cohorts in the Zika Brazilian Cohorts consortium."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "spastic hypertonia (at >3 months of age), osteotendinous hyperreflexia"
    explanation: >-
      Records the case definition used, including the age threshold, which is
      why this is not curated as a congenital finding.
  - reference: PMID:33320867
    reference_title: "Congenital Zika syndrome: A systematic review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "hydrocephalus, hypertonicity, and seizures; (b) in the osteoskeletal system: arthrogryposis and clubfoot"
    explanation: >-
      Independent corroboration from a systematic review of 46 studies, listing
      hypertonicity among the defining central nervous system signs.
- category: Gastrointestinal
  name: Dysphagia
  frequency: FREQUENT
  description: >-
    Swallowing dysfunction is the second dominant post-natal complication and
    the one with the clearest mortality consequence, through aspiration
    pneumonia. It is bulbar in origin, consistent with the brainstem
    involvement recorded in the histopathology section, and frequently forces
    gastrostomy.
  phenotype_term:
    preferred_term: Dysphagia
    term:
      id: HP:0002015
      label: Dysphagia
  evidence:
  - reference: PMID:41460891
    reference_title: "Characterization of 843 children with Zika-related microcephaly in the first three years of life: An individual participant data meta-analysis of 12 cohorts in the Zika Brazilian Cohorts consortium."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "In the pooled analyses, dysphagia was common and observed in 46.9% of children."
    explanation: >-
      Pooled frequency across 12 cohorts, the basis for the FREQUENT band.
  - reference: PMID:27509902
    reference_title: "Congenital Zika syndrome with arthrogryposis: retrospective case series study."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Dysphagia was present in six children (86%); two underwent gastrostomy and tracheostomy."
    explanation: >-
      Much higher frequency in the arthrogryposis series, consistent with
      dysphagia tracking overall neurological severity rather than being an
      independent feature.
  - reference: PMID:33320867
    reference_title: "Congenital Zika syndrome: A systematic review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Dysphagia can increase the risk of bronchoaspiration, resulting in aspiration pneumonia or death from asphyxiation, requiring gastrostomy in the affected infants"
    explanation: >-
      States the mechanism by which dysphagia becomes fatal, which is why it is
      curated as a phenotype in its own right rather than folded into feeding
      difficulty.
- category: Neurologic
  name: Global Developmental Delay
  description: >-
    Severe developmental delay across motor, language and cognitive domains is
    the expected long-term outcome of CZS. No frequency band is recorded here
    deliberately. The published pooled prevalences for neurodevelopmental delay
    in ZIKV-exposed children are drawn from infants who were normocephalic and
    apparently unaffected at birth, which is a different population from the
    one this entry describes; applying those figures to CZS would understate
    the delay substantially. The CZS-specific series are small and selected for
    severity, so they establish that the delay is severe without supporting a
    percentage.
  phenotype_term:
    preferred_term: Global developmental delay
    term:
      id: HP:0001263
      label: Global developmental delay
  evidence:
  - reference: PMID:39082517
    reference_title: "Clinical spectrum of congenital Zika virus infection in Brazil: Update and issues for research development."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Eighty-nine children with CZS and cerebral palsy undergoing rehabilitation showed evidence of severe developmental delays at the age of 1 year, according to the Bayley Scale of Infant and Toddler Development III (BSID-III)"
    explanation: >-
      Formal developmental assessment in a CZS cohort, establishing severity.
      The cohort is selected (children already in rehabilitation for cerebral
      palsy), which is why it supports the phenotype but not a frequency band.
- category: Growth
  name: Small for Gestational Age
  phenotype_term:
    preferred_term: Small for gestational age
    term:
      id: HP:0001518
      label: Small for gestational age
  evidence:
  - reference: PMID:33320867
    reference_title: "Congenital Zika syndrome: A systematic review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "abnormal visual function and low birthweight for gestational age"
    explanation: Low birthweight for gestational age among the defining features in the systematic review.

prevalence:
- population: Symptomatic ZIKV-infected pregnant women, Brazil (Ribeirao Preto region)
  measure_type: POINT_PREVALENCE
  prevalence_class: ABOVE_1_IN_1000
  rate_per_100000: 2500.0
  notes: >-
    Major signs of congenital Zika syndrome in 13 of 513 fetuses (2.5%) of
    symptomatic ZIKV-infected women in a prospective population-based cohort.
    This is a risk per infected pregnancy, not a population prevalence of the
    disease, and it is conditioned on the mother being symptomatic.
  evidence:
  - reference: PMID:32920998
    reference_title: "Early maternal Zika infection predicts severe neonatal neurological damage: results from the prospective Natural History of Zika Virus Infection in Gestation cohort study."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Of these, 13 (2.5%; 95% CI 1.5-4.3) presented with major signs of congenital Zika syndrome (CZS)."
    explanation: The proportion with major CZS signs, with its confidence interval.
- population: Liveborn infants of symptomatic ZIKV-infected women, Brazil
  measure_type: BIRTH_PREVALENCE
  prevalence_class: ABOVE_1_IN_1000
  rate_per_100000: 3900.0
  notes: >-
    Microcephaly or other CNS malformation in 19 of 489 liveborn infants (3.9%).
    Pregnancy losses occurred separately in 4.7% of the cohort, so the liveborn
    denominator understates total adverse outcomes.
  evidence:
  - reference: PMID:32920998
    reference_title: "Early maternal Zika infection predicts severe neonatal neurological damage: results from the prospective Natural History of Zika Virus Infection in Gestation cohort study."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Microcephaly or other CNS malformations were diagnosed in 1/4 (25.0%) stillbirths and in 19/489 (3.9%; 95% CI 2.5-5.9) of the liveborn infants."
    explanation: Birth prevalence among liveborn infants, alongside the stillbirth figure.

diagnosis:
- name: Maternal gestational age at infection as the dominant risk determinant
  description: >-
    Timing of maternal infection is the single strongest predictor of fetal
    outcome, and is the reason this entry treats first-trimester exposure as
    the high-risk window rather than as a stylistic emphasis. Neuropathology
    agrees with the epidemiology: lesion severity tracks gestational age at
    infection.
  evidence:
  - reference: PMID:32920998
    reference_title: "Early maternal Zika infection predicts severe neonatal neurological damage: results from the prospective Natural History of Zika Virus Infection in Gestation cohort study."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Fetal abnormalities were 14.0 (95% CI 7.6-26.0) times more likely with gestational infection occurring in ≤11 weeks."
    explanation: Quantifies the timing dependence with an effect size and interval.
  - reference: PMID:29167994
    reference_title: "Congenital Zika virus infection: a neuropathological review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The severity of the lesions is directly related to the gestational age, the most severe occurring when the mother is infected in the first trimester."
    explanation: >-
      Independent pathological confirmation of the same gradient, from tissue
      rather than from outcome statistics.
- name: Screening of apparently unaffected exposed infants
  description: >-
    A normal examination at birth does not exclude CZS-spectrum injury. In
    follow-up of infants classified as asymptomatic, a small proportion had eye
    abnormalities or CNS imaging findings and a larger proportion had
    neurological alert signs by three months. Hearing testing is likewise
    recommended for all infants born to women with evidence of ZIKV infection,
    including those who appear normal at birth.
  evidence:
  - reference: PMID:32920998
    reference_title: "Early maternal Zika infection predicts severe neonatal neurological damage: results from the prospective Natural History of Zika Virus Infection in Gestation cohort study."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "On follow up of 280 asymptomatic infants, 2/155 (1.3%) had eye abnormalities, 1/207 (0.5%) had CNS imaging findings and 16/199 (8%) presented neurological alert signs."
    explanation: Subclinical findings in infants who appeared unaffected, with denominators.
  - reference: PMID:27585248
    reference_title: "Hearing Loss in Infants with Microcephaly and Evidence of Congenital Zika Virus Infection - Brazil, November 2015-May 2016."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "all infants born to women with evidence of Zika virus infection during pregnancy should have their hearing tested, including infants who appear normal at birth"
    explanation: The screening recommendation that follows from ascertainment-dependent detection.

histopathology:
- name: Destructive cortical injury with calcification and migration disturbance
  description: >-
    The postmortem picture is destructive rather than purely hypoplastic, which
    is what distinguishes CZS from genetic primary microcephaly on tissue. It
    combines extensive parenchymal destruction, calcification, disturbed
    neuronal migration, and a reactive glial and microglial response, with
    occasional perivascular lymphocytic cuffing extending to the meninges.
  context: Postmortem CNS of fetuses and neonates infected early in gestation.
  evidence:
  - reference: PMID:29167994
    reference_title: "Congenital Zika virus infection: a neuropathological review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "there is extensive destruction of the hemispheric parenchyma, calcifications, various disturbances of neuronal migration, reactive gliosis, microglial hyperplasia and occasional perivascular cuffs of lymphocytes, also in the meninges"
    explanation: >-
      The full histological description, including the inflammatory component
      that a purely developmental account would not predict.

differential_diagnoses:
- name: Other congenital (TORCH) infections
  description: >-
    Congenital cytomegalovirus and toxoplasmosis produce overlapping
    intracranial calcification, microcephaly, chorioretinal disease and hearing
    loss, and are the principal differential. The pattern of calcification and
    the presence of arthrogryposis help, but neither is decisive, so
    discrimination rests on laboratory confirmation of the agent rather than on
    imaging phenotype.
  distinguishing_features:
  - >-
    Arthrogryposis with normal joints and neurogenic electromyographic findings
    is characteristic of CZS and is not a usual feature of congenital CMV or
    toxoplasmosis.
  - >-
    Sensorineural hearing loss occurs in CZS at a frequency similar to that seen
    with other congenital viral infections, so it does not discriminate between
    them.
  evidence:
  - reference: PMID:27585248
    reference_title: "Hearing Loss in Infants with Microcephaly and Evidence of Congenital Zika Virus Infection - Brazil, November 2015-May 2016."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "which is similar to that seen in association with other congenital viral infections"
    explanation: >-
      States that the hearing-loss frequency does not separate CZS from the other
      congenital infections, which is why it is listed as a non-discriminating
      feature.
- name: Genetic primary microcephaly
  description: >-
    Autosomal recessive primary microcephaly converges on the same
    progenitor-depletion endpoint but differs pathologically: CZS is a
    destructive process with prominent cell death, necrosis and calcification,
    whereas genetic primary microcephaly is hypoplastic without those features.
    The distinction is made on tissue and imaging rather than on head
    circumference.
  distinguishing_features:
  - >-
    Calcification, parenchymal destruction and perivascular inflammation favour
    congenital infection over a germline progenitor defect.
  evidence:
  - reference: PMID:29167994
    reference_title: "Congenital Zika virus infection: a neuropathological review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "there is extensive destruction of the hemispheric parenchyma, calcifications, various disturbances of neuronal migration, reactive gliosis, microglial hyperplasia"
    explanation: >-
      The destructive, inflammatory signature that separates CZS from hypoplastic
      genetic microcephaly on histology.

treatments:
- name: Supportive Care
  description: >-
    There is no specific antiviral therapy for congenital Zika syndrome.
    Management is supportive and multidisciplinary, addressing feeding
    difficulties, seizures, spasticity, and developmental needs.
  treatment_term:
    preferred_term: Supportive Care
    term:
      id: NCIT:C15747
      label: Supportive Care
- name: Physical and Developmental Therapy
  description: >-
    Early rehabilitative and developmental therapy to support motor function
    and mitigate the consequences of arthrogryposis and spasticity.
  therapeutic_modality: BEHAVIORAL
  treatment_term:
    preferred_term: physical therapy
    term:
      id: NCIT:C15302
      label: Physical Therapy
animal_models:
- name: Dengue-immune cynomolgus macaque ZIKV pregnancy model
  species: Cynomolgus macaque
  genotype: Wild type, DENV-immune prior to ZIKV challenge
  publication: PMID:37878671
  description: >-
    A nonhuman primate model of vertical transmission on a developmental
    timeline close to the human one, used to ask why some ZIKV-exposed fetuses
    are severely affected and others are not. Its answer is a maternal
    immunological one that this entry otherwise has no account of: prior dengue
    immunity worsens fetal outcome.
  modeled_mechanisms:
  - target: Impaired Neurogenesis and Congenital Cortical Malformation
    relationship: RECAPITULATES
    fidelity: HIGH
    description: >-
      Fetuses of DENV-immune macaques infected with ZIKV in early pregnancy
      developed significantly more severe CZS than naive controls, with reduced
      cortical thickness and increased neuronal death, haemorrhage, cellular
      infiltration, calcification and lissencephaly — the same lesion set
      reported in human postmortem material.
    limitations: >-
      The enhancement is demonstrated in macaques and has not been shown to
      operate in human pregnancy, so it is a candidate explanation for the
      variable human severity rather than an established one. The model also
      cannot separate antibody-dependent enhancement from other consequences of
      prior flavivirus exposure.
    readouts:
    - name: Fetal head circumference and biparietal diameter by serial ultrasound
      target: Impaired Neurogenesis and Congenital Cortical Malformation
      direction: DECREASED
      interpretation: >-
        In vivo growth measurement across gestation, directly comparable to the
        human antenatal measure.
      evidence:
      - reference: PMID:37878671
        reference_title: "Exacerbated Zika virus-induced neuropathology and microcephaly in fetuses of dengue-immune nonhuman primates."
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: "Ultrasound measurements of head circumference and biparietal diameter measurements taken sequentially throughout pregnancy demonstrated CZS in fetuses of DENV-immune pregnant macaques."
        explanation: The serial antenatal readout establishing microcephaly in the model.
    - name: Fetal brain histopathology
      target: Impaired Neurogenesis and Congenital Cortical Malformation
      direction: INCREASED
      interpretation: >-
        The lesion set matches human CZS neuropathology, which is what makes the
        model informative rather than merely a growth phenotype.
      evidence:
      - reference: PMID:37878671
        reference_title: "Exacerbated Zika virus-induced neuropathology and microcephaly in fetuses of dengue-immune nonhuman primates."
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: "severe CZS enhanced by DENV immunity was typified by reduced cortical thickness and increased frequency of neuronal death, hemorrhaging, cellular infiltrations, calcifications, and lissencephaly in fetal brains"
        explanation: The histological readouts, each of which has a human counterpart in this entry.
    evidence:
    - reference: PMID:37878671
      reference_title: "Exacerbated Zika virus-induced neuropathology and microcephaly in fetuses of dengue-immune nonhuman primates."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "We found significantly increased severity of congenital Zika syndrome (CZS) in fetuses of DENV-immune cynomolgus macaques infected with ZIKV in early pregnancy compared with naïve controls, which occurred despite no effect on maternal ZIKV infection or antibody responses."
      explanation: >-
        The core result, including the control that makes it a fetal rather than
        a maternal effect: maternal infection and antibody responses were
        unchanged.

discussions:
- discussion_id: gap_czs_human_model_translatability
  prompt: >-
    Which parts of the congenital Zika syndrome mechanism are directly supported
    in human fetal disease, and which remain model-dependent findings from human
    iPSC-derived neural progenitors, cerebral organoids, mouse embryos,
    non-human-primate organoids, or organotypic fetal systems?
  kind: HUMAN_MODEL_MISMATCH
  status: OPEN
  attaches_to:
  - pathophysiology#Transplacental Viral Transfer to the Fetal Compartment
  - pathophysiology#Neurotropic Entry into Fetal Neural Progenitors
  - pathophysiology#Antiviral Innate Immune Activation
  - pathophysiology#Viral Mitotic and Centrosome Cytopathy
  - pathophysiology#Neural Progenitor Apoptosis and Pool Depletion
  - pathophysiology#Impaired Neurogenesis and Congenital Cortical Malformation
  rationale: >-
    The disease pathograph now conforms to the viral neural progenitor cytopathy
    module, but much of the causal resolution comes from experimental systems
    rather than longitudinal human fetal material. Human autopsy anchors viral
    brain invasion and destructive malformation, while iPSC-derived hNPCs,
    cerebral organoids, mouse embryos, and non-human-primate organoids resolve
    entry, TLR3/TBK1 signaling, centrosome perturbation, apoptosis, and strain
    adaptation. This gap prevents a single model system from being treated as
    complete proof of the human prenatal disease sequence.
  evidence:
  - reference: PMID:27279226
    reference_title: "The Brazilian Zika virus strain causes birth defects in experimental models."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Mouse models often fail to reproduce the severely reduced brain size and
      pathological alterations found in human patients21,22, likely due to
      significant differences in gestation time and brain development between
      the two species.
    explanation: >-
      The paper explicitly identifies species and developmental-context
      differences that limit translation from mouse CZS models.
  - reference: PMID:27279226
    reference_title: "The Brazilian Zika virus strain causes birth defects in experimental models."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      Finally, our data using a non-human primate organoids suggested that the
      ZIKVBR might have experienced adaptive changes in human cells.
    explanation: >-
      Supports a strain- and host-cell-context mismatch gap for translating
      organoid and animal findings to human congenital infection.
  proposed_experiments:
  - experiment_id: exp_czs_cross_model_fetal_alignment
    name: CZS cross-model fetal-brain alignment experiment
    description: >-
      Compare matched ZIKV strains across human iPSC-derived cortical organoids,
      hNPC/radial-glial cultures, ethically available fetal cortical tissue or
      organotypic slices, and susceptible in vivo models, then map viral tropism,
      TLR3/TBK1 signaling, centrosome perturbation, apoptosis, progenitor loss,
      neurogenesis, and cortical thinning against human fetal autopsy endpoints.
    experiment_type:
      preferred_term: cross-model viral cortical malformation alignment experiment
    model_systems:
    - name: Human iPSC-derived cortical organoid ZIKV model
      description: >-
        Three-dimensional human cortical organoid system containing radial glia,
        neural progenitors, and early cortical neurons exposed to clinically
        relevant ZIKV strains.
      experimental_model_type: ORGANOID
      namo_type: namo:Organoid
      organism:
        preferred_term: human
        term:
          id: NCBITaxon:9606
          label: Homo sapiens
      tissue_term:
        preferred_term: cerebral cortex
        term:
          id: UBERON:0000956
          label: cerebral cortex
      cell_types:
      - preferred_term: radial glial cell
        term:
          id: CL:0000681
          label: radial glial cell
      - preferred_term: neural progenitor cell
        term:
          id: CL:0011020
          label: neural progenitor cell
      conditions:
      - congenital Zika syndrome
      - prenatal viral neural progenitor infection
      cell_source: Human induced pluripotent stem cells
      culture_system: Three-dimensional cortical organoid with controlled ZIKV exposure
    - name: Human fetal cortical tissue benchmark
      description: >-
        Postmortem or organotypic fetal cortical material, where ethically and
        legally available, used as a benchmark for viral localization, radial
        glial vulnerability, apoptosis, calcification, and cortical tissue
        architecture.
      experimental_model_type: PRIMARY_CELL_CULTURE
      organism:
        preferred_term: human
        term:
          id: NCBITaxon:9606
          label: Homo sapiens
      tissue_term:
        preferred_term: cerebral cortex
        term:
          id: UBERON:0000956
          label: cerebral cortex
      cell_types:
      - preferred_term: radial glial cell
        term:
          id: CL:0000681
          label: radial glial cell
      - preferred_term: neural progenitor cell
        term:
          id: CL:0011020
          label: neural progenitor cell
      conditions:
      - congenital Zika syndrome
      cell_source: Human fetal cortical tissue
      culture_system: Fetal cortical tissue benchmark or organotypic slice where available
    perturbations:
    - name: Matched congenital ZIKV strain exposure
      target: pathophysiology#Neurotropic Entry into Fetal Neural Progenitors
      description: >-
        Expose model systems to matched congenital outbreak isolates and
        laboratory-passaged controls under controlled inoculum and developmental
        timing.
    readouts:
    - name: Viral tropism and replication in radial glia and neural progenitors
      target: pathophysiology#Neurotropic Entry into Fetal Neural Progenitors
      biological_processes:
      - preferred_term: viral genome replication
        term:
          id: GO:0019079
          label: viral genome replication
        modifier: INCREASED
      assays:
      - preferred_term: viral RNA quantification
      - preferred_term: immunostaining
      - preferred_term: single-cell RNA sequencing
      direction: POSITIVE
    - name: Innate immune and centrosome cytopathy
      target: pathophysiology#Viral Mitotic and Centrosome Cytopathy
      biological_processes:
      - preferred_term: toll-like receptor signaling pathway
        term:
          id: GO:0002224
          label: toll-like receptor signaling pathway
        modifier: INCREASED
      - preferred_term: centrosome cycle
        term:
          id: GO:0007098
          label: centrosome cycle
        modifier: ABNORMAL
      assays:
      - preferred_term: phospho-TBK1 localization assay
      - preferred_term: centrosome immunostaining
      - preferred_term: single-cell RNA sequencing
      direction: POSITIVE
    - name: Progenitor survival and cortical growth
      target: pathophysiology#Neural Progenitor Apoptosis and Pool Depletion
      biological_processes:
      - preferred_term: apoptotic process
        term:
          id: GO:0006915
          label: apoptotic process
        modifier: INCREASED
      - preferred_term: neurogenesis
        term:
          id: GO:0022008
          label: neurogenesis
        modifier: DECREASED
      assays:
      - preferred_term: cleaved caspase-3 immunostaining
      - preferred_term: progenitor and neuron marker quantification
      - preferred_term: cortical thickness measurement
      direction: NEGATIVE
    controls:
    - name: Mock-infected controls
      description: Matched model systems exposed to vehicle without infectious virus.
    - name: Strain-matched heat-inactivated viral controls
      description: Controls for innate immune stimulation not requiring productive infection.
    decision_criterion: >-
      The CZS mechanism is strengthened if human organoids, fetal tissue
      benchmarks, and susceptible in vivo models show concordant radial-glial or
      progenitor tropism, TLR3/TBK1 and centrosome perturbation, apoptosis,
      progenitor depletion, reduced neurogenesis, and cortical thinning under
      matched strain and developmental timing. Major divergence would localize
      model-specific branches that should not be generalized to human CZS.
    would_support:
    - pathophysiology#Neurotropic Entry into Fetal Neural Progenitors
    - pathophysiology#Antiviral Innate Immune Activation
    - pathophysiology#Viral Mitotic and Centrosome Cytopathy
    - pathophysiology#Neural Progenitor Apoptosis and Pool Depletion
    - pathophysiology#Impaired Neurogenesis and Congenital Cortical Malformation
    would_refute:
    - pathophysiology#Viral Mitotic and Centrosome Cytopathy
    - pathophysiology#Neural Progenitor Apoptosis and Pool Depletion
- discussion_id: gap_czs_specific_therapy
  prompt: >-
    No approved antiviral or disease-modifying therapy exists for congenital
    Zika syndrome; candidate small molecules (e.g., nucleoside analogues) and
    TLR3-pathway modulation have shown effects only in experimental models.
    Which interventions, if any, can interrupt the progenitor-cytopathy cascade
    within the narrow prenatal therapeutic window?
  kind: KNOWLEDGE_GAP
  status: OPEN
  attaches_to:
  - pathophysiology#Antiviral Innate Immune Activation
  - pathophysiology#Neural Progenitor Apoptosis and Pool Depletion
  rationale: >-
    Experimental evidence (e.g., TLR3 inhibition reducing ZIKV phenotypes in
    organoids) suggests mechanistically rational intervention points, but no
    therapy has translated to human prenatal use, and the destructive,
    early-onset nature of the progenitor cytopathy makes the therapeutic window
    extremely narrow. This gap motivates prevention (vector control, avoidance
    of exposure in pregnancy) as the current mainstay.
- discussion_id: mismatch_czs_tnt_placental_transmission
  prompt: >-
    Does tunneling-nanotube-mediated viral spread operate in the human placenta,
    and how much of the mouse placental-injury phenotype transfers to human
    congenital Zika disease?
  kind: HUMAN_MODEL_MISMATCH
  status: OPEN
  attaches_to:
  - pathophysiology#Tunneling Nanotube-Mediated Intercellular Viral Spread
  - pathophysiology#Placental Infection
  - pathophysiology#Placental Architectural and Functional Disruption
  - pathophysiology#Fetal Growth Restriction
  - pathophysiology#Transplacental Viral Transfer to the Fetal Compartment
  rationale: >-
    The TNT arm of transplacental dissemination is established entirely in mouse
    pregnancy models, by comparing a TNT-competent virus with an NS1
    residue-40-52 TNT-deficient mutant. Two distinct translational questions
    follow. First, TNTs have not been demonstrated to carry ZIKV between cells
    in human placental tissue in vivo, so the mechanism is a strong candidate
    rather than an established human route. Second, and more concretely, the
    architectural readout does not transfer at all: the junctional zone and
    labyrinth are compartments of the rodent placenta with no direct human
    homolog, so "altered junctional-to-labyrinth architecture" cannot be
    restated as a human placental finding. The nearest human comparison points
    the other way: in full-term placentas from three ZIKV-infected women, viral
    NS3 antigen localized to Hofbauer cells while the placentas showed no
    anatomic defects (PMID:31709049, the publication behind the GSE139181
    dataset already curated in this entry) — a small series, and not a test of
    the TNT mechanism, but not obviously the same picture either. Fetal growth
    restriction is therefore curated as an ORGANISM-scale pathophysiology node
    carrying model-organism evidence, and is deliberately absent from
    `phenotypes:`, which would require human evidence.
  proposed_experiments:
  - experiment_id: exp_czs_tnt_human_placenta
    name: Detection of ZIKV-laden tunneling nanotubes in human placental explants
    description: >-
      Live imaging and correlative electron microscopy of ZIKV-infected primary
      human trophoblast and placental explant cultures, scoring actin-rich
      intercellular conduits carrying viral components, with the NS1
      residue-40-52 TNT-deficient mutant as the negative control.
  evidence:
  - reference: PMID:42627154
    reference_title: "Tunneling nanotubes contribute to Zika virus pathogenesis at the maternal-fetal interface in vivo."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Here, we investigated the in vivo role of TNTs in ZIKV maternal-fetal transmission using complementary pregnancy models."
    explanation: Establishes that the in vivo evidence for the TNT arm comes from animal pregnancy models rather than human tissue.
  - reference: PMID:42627154
    reference_title: "Tunneling nanotubes contribute to Zika virus pathogenesis at the maternal-fetal interface in vivo."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "ZIKVΔTNT infection was associated with reduced placental pathology, altered junctional-to-labyrinth architecture, improved placental efficiency, and protection from fetal growth restriction."
    explanation: Names the junctional-to-labyrinth readout, which is a rodent placental compartment measure with no human equivalent.
  - reference: PMID:31709049
    reference_title: "Immunological observations and transcriptomic analysis of trimester-specific full-term placentas from three Zika virus-infected women."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Although ZIKV NS3 antigens co-localised to placental Hofbauer cells, the placentas showed no anatomic defects."
    explanation: >-
      The human placental comparison invoked in this mismatch. Infected human
      placentas carried viral antigen without the structural defects the mouse
      models show.
- discussion_id: gap_czs_ns1_tnt_therapeutic_target
  prompt: >-
    Is the NS1 determinant of tunneling-nanotube formation (residues 40-52) a
    tractable antiviral target for preventing transplacental ZIKV transmission,
    and does the same TNT route operate in other vertically transmitted viruses?
  kind: KNOWLEDGE_GAP
  status: OPEN
  attaches_to:
  - pathophysiology#Tunneling Nanotube-Mediated Intercellular Viral Spread
  rationale: >-
    A discrete viral protein determinant whose loss reduces dissemination,
    placental injury, and fetal growth restriction without abolishing viral
    viability is an unusually clean target hypothesis, and it addresses the
    transmission step rather than the downstream progenitor cytopathy — a much
    wider therapeutic window than the one the existing therapy gap describes.
    Nothing here has been tested as an intervention: the evidence is a
    genetically engineered mutant virus, not a drug or an antibody, and no
    NS1-directed agent has been shown to block TNT formation. The authors also
    raise, without testing, whether TNTs matter for other vertically transmitted
    or emerging viruses; that generalization has no evidence in this entry and
    should not be curated onto other disease entries on the strength of this
    paper alone.
  evidence:
  - reference: PMID:42627154
    reference_title: "Tunneling nanotubes contribute to Zika virus pathogenesis at the maternal-fetal interface in vivo."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "These findings identify TNTs as a previously underappreciated pathway of viral transmission during pregnancy and suggest new therapeutic targets."
    explanation: The therapeutic-target claim is the authors' proposal, not a tested intervention, which is what makes this a gap rather than a treatment entry.
  - reference: PMID:42627154
    reference_title: "Tunneling nanotubes contribute to Zika virus pathogenesis at the maternal-fetal interface in vivo."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "More broadly, TNTs may contribute to the pathogenesis of other vertically transmitted or emerging viral infections."
    explanation: Records the cross-pathogen generalization as an explicitly speculative statement.
- discussion_id: gap_czs_dengue_immunity_enhancement
  prompt: >-
    Does pre-existing maternal dengue immunity worsen fetal outcome in human
    congenital Zika syndrome, as it does in macaques?
  kind: HUMAN_MODEL_MISMATCH
  status: OPEN
  attaches_to:
  - pathophysiology#Transplacental Viral Transfer to the Fetal Compartment
  - pathophysiology#Impaired Neurogenesis and Congenital Cortical Malformation
  - animal_models#Dengue-immune cynomolgus macaque ZIKV pregnancy model
  rationale: >-
    Why some ZIKV-exposed fetuses are severely affected and others are not is
    the largest unexplained variance in this disease, and the entry's timing
    account does not fully cover it. A nonhuman primate experiment supplies a
    candidate: fetuses of dengue-immune macaques infected in early pregnancy
    developed significantly worse CZS than naive controls, with no difference in
    maternal infection or antibody response — locating the effect in the fetus
    rather than in maternal viral control.

    The translational question is unusually consequential because ZIKV and DENV
    co-circulate across most of the affected geography, so a large share of
    women entering a Zika outbreak are dengue-immune. If the enhancement operates
    in humans, prior dengue serostatus would be a risk stratifier available
    before conception and would also bear on flavivirus vaccination strategy in
    women of childbearing age. If it does not, the macaque result localises a
    species-specific branch that should not inform human counselling.

    This is recorded as a mismatch rather than a knowledge gap because the
    evidence exists and is strong in the model; what is unknown is whether it
    transfers.
  proposed_experiments:
  - experiment_id: exp_czs_denv_serostatus_stratified_cohort
    name: DENV-serostatus-stratified prospective cohort of ZIKV-infected pregnancies
    description: >-
      In a prospective cohort of pregnancies with confirmed ZIKV infection,
      determine pre-pregnancy or first-trimester DENV serostatus and compare the
      incidence and severity of CZS between DENV-immune and DENV-naive mothers,
      stratifying by gestational age at infection so the two risk factors are not
      confounded.
    would_support:
    - pathophysiology#Impaired Neurogenesis and Congenital Cortical Malformation
    supporting_outcome:
    - >-
      CZS is more frequent or more severe in the offspring of DENV-immune
      mothers after adjustment for timing, supporting transfer of the macaque
      enhancement to human pregnancy.
    refuting_outcome:
    - >-
      CZS incidence and severity are independent of maternal DENV serostatus,
      indicating the enhancement is model-specific and should not be used for
      human risk stratification.

datasets:
- accession: geo:GSE234062
  title: Human Otic progenitor cell models of congenital hearing loss applied to to Zika virus and cytomegalovirus infections
  description: Congenital hearing loss is a common chronic condition affecting children in both developed and developing nations. In many cases, congenital hearing loss is ultimately attributed to viral infection, most often by cytomegalovirus (CMV), but also in Congenital Zika Syndrome (CZS). The mechanisms by which CMV and ZIKV virus cause these cranial developmental defects have not been elucidated. Inner ear development has been particularly difficult to study, given the inaccessibility and scarcity of the tissue in animal models or on human autopsy; however, it is now possible to culture stem-cell derived otic progenitor cells (OPCs).
  organism:
    preferred_term: human
    term:
      id: NCBITaxon:9606
      label: Homo sapiens
  data_type: BULK_RNA_SEQ
  sample_count: 36
  publication: PMID:38440980
  notes: Identified by GEO DataSets index search for Congenital Zika Syndrome (scripts/discover_datasets.py); accession and metadata verified against NCBI E-utilities on 2026-08-01. Title, sample count, and organism are GEO's own values.
- accession: geo:GSE102128
  title: RNA-seq of hiPSCs-derived NPCs from 3 pairs of dizygotic discordant twins for Congenital Zika syndrome
  description: Congenital Zika syndrome (CZS), caused by Zika virus (ZIKV) infection, has been associated to impairment of early brain development, particularly related to neural progenitor cells (NPCs) survival and growth. In this work we report in a high-throughput manner (RNA-Seq) the differences in the transcriptomes of hiPSCs(human induced pluripotent stem cells)-derived NPCs from 3 pairs of discordant twins for Congenital Zika syndrome (CZS).
  organism:
    preferred_term: human
    term:
      id: NCBITaxon:9606
      label: Homo sapiens
  data_type: BULK_RNA_SEQ
  sample_count: 6
  publication: PMID:29396410
  notes: Identified by GEO DataSets index search for Congenital Zika Syndrome (scripts/discover_datasets.py); accession and metadata verified against NCBI E-utilities on 2026-08-01. Title, sample count, and organism are GEO's own values.
- accession: geo:GSE139181
  title: Transcriptomics analysis of trimester-specific full-term placentas from three Zika virus-infected women
  description: Effects of Zika virus (ZIKV) infection on placental development during pregnancy are unclear. In this study, full-term placentas from three women, each infected with ZIKV during specific pregnancy trimesters, were harvested for anatomic, immunologic and transcriptomic analysis. Each woman exhibited a unique immune response with raised IL-1RA, IP-10, EGF and RANTES expression, and neutrophil numbers during the acute infection phase. Although ZIKV NS3 antigens co-localized to placental Hofbauer cells, the placentas showed no anatomical defects.
  organism:
    preferred_term: human
    term:
      id: NCBITaxon:9606
      label: Homo sapiens
  data_type: BULK_RNA_SEQ
  sample_count: 33
  publication: PMID:31709049
  notes: Identified by GEO DataSets index search for Congenital Zika Syndrome (scripts/discover_datasets.py); accession and metadata verified against NCBI E-utilities on 2026-08-01. Title, sample count, and organism are GEO's own values.

references:
- reference: PMID:26862926
  title: "Zika Virus Associated with Microcephaly."
- reference: PMID:26952870
  title: "Zika Virus Infects Human Cortical Neural Progenitors and Attenuates Their Growth."
- reference: PMID:27038591
  title: "Expression Analysis Highlights AXL as a Candidate Zika Virus Entry Receptor in Neural Stem Cells."
- reference: PMID:27064148
  title: "Zika virus impairs growth in human neurospheres and brain organoids."
- reference: PMID:27066743
  title: "Type III Interferons Produced by Human Placental Trophoblasts Confer Protection against Zika Virus Infection."
- reference: PMID:27162029
  title: "Zika Virus Depletes Neural Progenitors in Human Cerebral Organoids through Activation of the Innate Immune Receptor TLR3."
- reference: PMID:27179424
  title: "Zika Virus Disrupts Neural Progenitor Development and Leads to Microcephaly in Mice."
- reference: PMID:27247001
  title: "Zika Virus Infects Human Placental Macrophages."
- reference: PMID:27279226
  title: "The Brazilian Zika virus strain causes birth defects in experimental models."
- reference: PMID:27443522
  title: "Zika Virus Targets Different Primary Human Placental Cells, Suggesting Two Routes for Vertical Transmission."
- reference: PMID:27509902
  title: "Congenital Zika syndrome with arthrogryposis: retrospective case series study."
- reference: PMID:27568284
  title: "Zika Virus Disrupts Phospho-TBK1 Localization and Mitosis in Human Neuroepithelial Stem Cells and Radial Glia."
- reference: PMID:27585248
  title: "Hearing Loss in Infants with Microcephaly and Evidence of Congenital Zika Virus Infection - Brazil, November 2015-May 2016."
- reference: PMID:28132835
  title: "Recent Zika Virus Isolates Induce Premature Differentiation of Neural Progenitors in Human Brain Organoids."
- reference: PMID:29167994
  title: "Congenital Zika virus infection: a neuropathological review."
- reference: PMID:30252119
  title: "Zika Virus Infection during Pregnancy and Sensorineural Hearing Loss among Children at 3 and 24 Months Post-Partum."
- reference: PMID:31709049
  title: "Immunological observations and transcriptomic analysis of trimester-specific full-term placentas from three Zika virus-infected women."
- reference: PMID:32065676
  title: "Early epilepsy in children with Zika-related microcephaly in a cohort in Recife, Brazil: Characteristics, electroencephalographic findings, and treatment response."
- reference: PMID:32920998
  title: "Early maternal Zika infection predicts severe neonatal neurological damage: results from the prospective Natural History of Zika Virus Infection in Gestation cohort study."
- reference: PMID:33320867
  title: "Congenital Zika syndrome: A systematic review."
- reference: PMID:37878671
  title: "Exacerbated Zika virus-induced neuropathology and microcephaly in fetuses of dengue-immune nonhuman primates."
- reference: PMID:39082517
  title: "Clinical spectrum of congenital Zika virus infection in Brazil: Update and issues for research development."
- reference: PMID:41460891
  title: "Characterization of 843 children with Zika-related microcephaly in the first three years of life: An individual participant data meta-analysis of 12 cohorts in the Zika Brazilian Cohorts consortium."
- reference: PMID:42627154
  title: "Tunneling nanotubes contribute to Zika virus pathogenesis at the maternal-fetal interface in vivo."
📚

References & Deep Research

References

24
Zika Virus Associated with Microcephaly.
No top-level findings curated for this source.
Zika Virus Infects Human Cortical Neural Progenitors and Attenuates Their Growth.
No top-level findings curated for this source.
Expression Analysis Highlights AXL as a Candidate Zika Virus Entry Receptor in Neural Stem Cells.
No top-level findings curated for this source.
Zika virus impairs growth in human neurospheres and brain organoids.
No top-level findings curated for this source.
Type III Interferons Produced by Human Placental Trophoblasts Confer Protection against Zika Virus Infection.
No top-level findings curated for this source.
Zika Virus Depletes Neural Progenitors in Human Cerebral Organoids through Activation of the Innate Immune Receptor TLR3.
No top-level findings curated for this source.
Zika Virus Disrupts Neural Progenitor Development and Leads to Microcephaly in Mice.
No top-level findings curated for this source.
Zika Virus Infects Human Placental Macrophages.
No top-level findings curated for this source.
The Brazilian Zika virus strain causes birth defects in experimental models.
No top-level findings curated for this source.
Zika Virus Targets Different Primary Human Placental Cells, Suggesting Two Routes for Vertical Transmission.
No top-level findings curated for this source.
Congenital Zika syndrome with arthrogryposis: retrospective case series study.
No top-level findings curated for this source.
Zika Virus Disrupts Phospho-TBK1 Localization and Mitosis in Human Neuroepithelial Stem Cells and Radial Glia.
No top-level findings curated for this source.
Hearing Loss in Infants with Microcephaly and Evidence of Congenital Zika Virus Infection - Brazil, November 2015-May 2016.
No top-level findings curated for this source.
Recent Zika Virus Isolates Induce Premature Differentiation of Neural Progenitors in Human Brain Organoids.
No top-level findings curated for this source.
Congenital Zika virus infection: a neuropathological review.
No top-level findings curated for this source.
Zika Virus Infection during Pregnancy and Sensorineural Hearing Loss among Children at 3 and 24 Months Post-Partum.
No top-level findings curated for this source.
Immunological observations and transcriptomic analysis of trimester-specific full-term placentas from three Zika virus-infected women.
No top-level findings curated for this source.
Early epilepsy in children with Zika-related microcephaly in a cohort in Recife, Brazil: Characteristics, electroencephalographic findings, and treatment response.
No top-level findings curated for this source.
Early maternal Zika infection predicts severe neonatal neurological damage: results from the prospective Natural History of Zika Virus Infection in Gestation cohort study.
No top-level findings curated for this source.
Congenital Zika syndrome: A systematic review.
No top-level findings curated for this source.
Exacerbated Zika virus-induced neuropathology and microcephaly in fetuses of dengue-immune nonhuman primates.
No top-level findings curated for this source.
Clinical spectrum of congenital Zika virus infection in Brazil: Update and issues for research development.
No top-level findings curated for this source.
Characterization of 843 children with Zika-related microcephaly in the first three years of life: An individual participant data meta-analysis of 12 cohorts in the Zika Brazilian Cohorts consortium.
No top-level findings curated for this source.
Tunneling nanotubes contribute to Zika virus pathogenesis at the maternal-fetal interface in vivo.
No top-level findings curated for this source.

Deep Research

1
Falcon
1. Disease Information
Edison Scientific Literature 53 citations 2026-06-11T18:33:05.839962

1. Disease Information

1.1 Concise overview

Congenital Zika syndrome (CZS) is a specific pattern of congenital anomalies and long-term neurodevelopmental disabilities caused by vertical (mother-to-child) transmission of Zika virus (ZIKV) during pregnancy, with the central nervous system (CNS) as the primary target and frequent multisystem involvement (ocular, musculoskeletal, feeding/swallowing, and other neurologic comorbidities). (martelli2024clinicalspectrumof pages 1-2, crisantolopez2023congenitalzikasyndrome pages 1-2)

1.2 Key identifiers (ontology/classification)

  • ICD-11: Congenital Zika virus infection KA62.0 (explicitly stated as the ICD-11 classification in a 2024 Brazil-focused clinical spectrum update). Publication date: 2024-07; URL: https://doi.org/10.1590/0037-8682-0153-2024 (martelli2024clinicalspectrumof pages 2-3)
  • MeSH (related concept): Zika Virus Infection (MeSH concept id D000071243) appears in ClinicalTrials.gov structured metadata (not specific to congenital infection, but relevant controlled vocabulary). (NCT03110770 chunk 4)
  • MONDO ID / ICD-10 / Orphanet / OMIM / MeSH for “Congenital Zika Syndrome”: Not available from the retrieved full-text evidence in this run; only ICD-11 KA62.0 was explicitly reported. (martelli2024clinicalspectrumof pages 2-3, crisantolopez2023congenitalzikasyndrome pages 8-10)

1.3 Common synonyms / alternative names

  • “Congenital Zika syndrome (CZS)” (martelli2024clinicalspectrumof pages 1-2, crisantolopez2023congenitalzikasyndrome pages 1-2)
  • “Congenital Zika virus infection” (ICD-11 KA62.0 term; also used as a primary label in the 2024 Brazil review) (martelli2024clinicalspectrumof pages 2-3)
  • “Zika-related microcephaly” is frequently used to refer to severe CZS presentations in cohort literature. (mirandafilho2025characterizationof843 pages 2-3)

1.4 Evidence provenance (individual patients vs aggregated)

Evidence in this report is derived from both (i) aggregated resources (systematic reviews, meta-analyses, surveillance reviews) and (ii) primary cohorts (prospective cohorts, pooled individual-participant data analyses, caregiver studies using validated scales). (mirandafilho2025characterizationof843 pages 2-3, rabe2025areviewof pages 4-5, melo2023congenitalzikasyndrome pages 11-12)

2. Etiology

2.1 Disease causal factors

Primary cause: In utero ZIKV infection (vertical transmission), which can occur even when maternal infection is asymptomatic; congenital manifestations arise from placental infection and fetal neurotropism with injury to neural progenitors and neurodevelopmental disruption. (crisantolopez2023congenitalzikasyndrome pages 4-5, wong2025zikavirusand pages 3-5)

2.2 Risk factors

  • Gestational timing: Earlier maternal infection increases risk of adverse outcomes. A matched cohort study reported that 44% of pregnancies with first-trimester maternal infection had at least one adverse child event, and first-trimester infection had OR 11.2 (95% CI 3.6–35.0) for adverse outcomes vs third trimester. Publication date: 2025-01; URL: https://doi.org/10.1542/peds.2024-067552 (venancio2025earlyandlongterm pages 1-3)
  • Population-level risk of congenital outcomes among infected pregnancies: A large systematic review/meta-analysis estimated CZS proportion 4.65% (95% CI 3.38–6.67%) among ZIKV-infected pregnancies. Publication date: 2026-02; URL: https://doi.org/10.1038/s44360-025-00051-4 (mccain2026asystematicreview pages 1-2)

2.3 Protective factors

Evidence for protective factors is limited and heterogeneous. In one longitudinal cohort of normocephalic preschool children in Colombia (not restricted to CZS cases), daycare/school attendance was associated with a lower risk of neurodevelopmental delay, while prenatal ZIKV exposure was not significantly associated with delay in that cohort; this represents a social/environmental protective association rather than biological protection. (shah2024analysisofcongenital pages 13-15)

2.4 Gene–environment interactions (GxE)

A key hypothesized interaction is prior flavivirus immunity and antibody-dependent enhancement (ADE) mechanisms at the maternal–fetal interface, which may facilitate placental infection/transfer via Fcγ receptor pathways (conceptualized in placental-interface reviews). (wong2025zikavirusand pages 2-3)

3. Phenotypes (clinical spectrum)

3.1 Core phenotype summary (current understanding)

CZS is defined by a recognizable phenotype including severe/disproportionate microcephaly, characteristic neuroimaging abnormalities (calcifications, ventriculomegaly, cortical atrophy/malformations), ocular lesions (retinal/optic nerve), congenital contractures (arthrogryposis/clubfoot), and frequent neurologic comorbidities such as epilepsy and dysphagia. (martelli2024clinicalspectrumof pages 1-2, martelli2024clinicalspectrumof pages 2-3)

3.2 Quantitative phenotype frequencies and statistics (selected recent syntheses)

A consolidated phenotype-frequency table with suggested HPO terms and quantitative ranges is provided below.

Domain Specific phenotype (suggested HPO term) Quantitative estimate(s) Population / study type Notes Supporting citation IDs
CNS Microcephaly (HP:0000252) ~4% absolute risk of microcephaly after confirmed maternal ZIKV infection; baseline pre-epidemic microcephaly ~2.0/10,000 newborns Brazil meta-analysis/review summarized in 2024 update Signature phenotype; risk estimate refers to infected pregnancies/offspring follow-up (martelli2024clinicalspectrumof pages 1-2)
CNS Severe microcephaly (HP:0011451) 384/601 (63.9%) among children with microcephaly at birth; moderate 217/601 (36.1%) IPD meta-analysis of 12 Brazilian cohorts, n=843 children with Zika-related microcephaly Captures severity distribution among those already affected (mirandafilho2025characterizationof843 pages 2-3)
CNS Postnatal microcephaly (HP:0000252) 172/843 (20.4%) IPD meta-analysis of 12 Brazilian cohorts Highlights progression after birth in some exposed infants (mirandafilho2025characterizationof843 pages 2-3)
Neuroimaging Intracranial calcifications (HP:0002514) ~80% across pooled Brazilian cohorts; 94% in systematic clinicopathologic review IPD meta-analysis; systematic review of Brazilian outbreak cohorts One of the most consistent structural markers of severe CZS (mirandafilho2025characterizationof843 pages 2-3, shah2024analysisofcongenital pages 13-15)
Neuroimaging Ventriculomegaly (HP:0002119) ~80% across pooled cohorts; 89% in systematic clinicopathologic review IPD meta-analysis; systematic review Often co-occurs with calcifications and cortical atrophy (mirandafilho2025characterizationof843 pages 2-3, shah2024analysisofcongenital pages 13-15)
Neuroimaging Cortical atrophy / reduced cerebral parenchyma (HP:0007373, HP:0002059) ~50% cortical atrophy/developmental disorders across pooled cohorts; reduced cerebral parenchyma 86%; malformation of cortical development/lack of gyri 78% IPD meta-analysis; systematic review Marks severe prenatal brain disruption (mirandafilho2025characterizationof843 pages 2-3, shah2024analysisofcongenital pages 13-15)
CNS Neurological alteration of any type 18.7% Zika Brazilian Cohorts pooled pregnancy/child follow-up Broader than microcephaly alone (martelli2024clinicalspectrumof pages 3-4)
CNS Any abnormality after antenatal exposure 24.7% had ≥1 alteration Zika Brazilian Cohorts pooled pregnancy/child follow-up Includes isolated abnormalities; not restricted to classic CZS (martelli2024clinicalspectrumof pages 3-4)
CNS Epilepsy / seizures (HP:0001250) 37.7%–71.4% in reviewed cohorts; 71.4% cumulative incidence within 2 years in one microcephaly cohort; 30%–80% across 12-cohort IPD; 91% in clinicopathologic review Brazil cohorts, systematic reviews, IPD meta-analysis Often early-onset; epileptic spasms may begin after 3 months (martelli2024clinicalspectrumof pages 2-3, mirandafilho2025characterizationof843 pages 2-3, shah2024analysisofcongenital pages 13-15)
Ocular Ocular abnormalities overall (HP:0000478) 21.4%–70%; about one-third in one multisite Brazilian study Brazil cohorts/review Some affected infants had ocular findings without microcephaly (martelli2024clinicalspectrumof pages 2-3)
Ocular Fundus abnormalities (HP:0000580) 0%–67.1% IPD meta-analysis of 12 Brazilian cohorts Wide heterogeneity across sites (mirandafilho2025characterizationof843 pages 2-3)
Ocular Optic nerve abnormalities (HP:0001138) 0%–36.5% across cohorts; 67% in systematic clinicopathologic review IPD meta-analysis; systematic review Includes optic nerve pallor/atrophy (mirandafilho2025characterizationof843 pages 2-3, shah2024analysisofcongenital pages 13-15)
Ocular Retinal lesions / chorioretinal atrophy/scarring (HP:0000556, HP:0007703) 79% retinal lesions in systematic review; examples: chorioretinal atrophy 11/17 eyes (64.7%), macular chorioretinal atrophy/scarring 45.8% Systematic review; outbreak case series summarized in review Major cause of visual impairment (shah2024analysisofcongenital pages 13-15, shah2024analysisofcongenital pages 10-12)
Auditory Hearing abnormality (HP:0000365) 0%–50% across cohorts; ~20% in systematic clinicopathologic review IPD meta-analysis; systematic review Conductive or sensorineural deficits reported (mirandafilho2025characterizationof843 pages 2-3, shah2024analysisofcongenital pages 1-3, shah2024analysisofcongenital pages 13-15)
Musculoskeletal Arthrogryposis / congenital contractures (HP:0002804, HP:0001371) ~15% in systematic review; 19.0% (n=4) in one summarized series Systematic review; case series summarized in review Commonly associated with severe CNS disease and hypertonia (shah2024analysisofcongenital pages 13-15, shah2024analysisofcongenital pages 10-12)
Musculoskeletal Hypertonia / spasticity (HP:0001276, HP:0001257) Hypertonia up to 92%; spasms/spasticity 97%; appendicular hypertonia 94.8% in one series Systematic review; summarized cohorts Major contributor to cerebral palsy phenotype (shah2024analysisofcongenital pages 13-15, shah2024analysisofcongenital pages 10-12)
Musculoskeletal Quadriparesis / severe motor impairment (HP:0002510, HP:0001270) Quadriparesis 92%; one cohort reported 81% severe motor function impairment Systematic review; Brazil cohort review Usually evident in infancy/early childhood (shah2024analysisofcongenital pages 13-15, martelli2024clinicalspectrumof pages 3-4)
Feeding-Growth Dysphagia / swallowing dysfunction (HP:0002015) 17.9%–70% across reviews; 22.2%–67.7% across 12-cohort IPD; oropharyngeal dysphagia 79.3% in microcephaly vs 8.5% in normocephalic peers Brazil cohorts, review, IPD meta-analysis Major driver of malnutrition and aspiration risk; ~20% required alternative feeding by age 2 (martelli2024clinicalspectrumof pages 3-4, martelli2024clinicalspectrumof pages 2-3, mirandafilho2025characterizationof843 pages 2-3)
Feeding-Growth Low birth weight (HP:0001518) 10%–43.8% across cohorts; 23.9% in one infant cohort up to 12 months IPD meta-analysis; observational cohort Reflects prenatal growth effects and heterogeneity (mirandafilho2025characterizationof843 pages 2-3)
Feeding-Growth Linear growth deficit / short stature (HP:0004322) 39.1% of length-for-age measurements below deficit threshold in one cohort; stunting in literature 14.3%–57.1% Infant cohort; systematic review of malnutrition studies Often linked to dysphagia and feeding difficulty (mirandafilho2025characterizationof843 pages 2-3)
Feeding-Growth Underweight / wasting (HP:0004325) Underweight 14.3%–54.4%; wasting 4.3%–48.0% Systematic review of observational studies in children with CZS Reflects chronic nutritional vulnerability (mirandafilho2025characterizationof843 pages 2-3)
Other Urological impairment Frequency not pooled; repeatedly reported as common comorbidity Brazil cohort review Included as part of broader multisystem CZS spectrum (martelli2024clinicalspectrumof pages 1-2)
Other Hospitalization burden 41.4% in children with microcephaly vs 16.2% in normocephalic peers Brazil cohorts summarized in review Likely reflects feeding, neurologic, and respiratory complications (martelli2024clinicalspectrumof pages 3-4)
Other Mortality 11.3-fold higher mortality up to 36 months in children with CZS / Zika-related microcephaly vs unexposed peers Systematic review summary Severe disease substantially increases early-childhood mortality (shah2024analysisofcongenital pages 13-15)
Epidemiology statistic Estimate Population / timeframe Notes Supporting citation IDs
CZS proportion among ZIKV-infected pregnancies 4.65% (95% CI 3.38–6.67%) Systematic review/meta-analysis of ZIKV epidemiology Pooled estimate for CZS among infected pregnancies (mccain2026asystematicreview pages 1-2, mccain2026asystematicreview pages 7-7)
Countries/territories with documented autochthonous mosquito-borne ZIKV transmission 92 Global status as of Dec 2023 Transmission likely underrecognized because many infections are asymptomatic/mild (rabe2025areviewof pages 1-2, rabe2025areviewof pages 3-4)
Brazil confirmed CZS cases 1,858 confirmed; 2,960 suspected under investigation 2015 to epidemiological week 31 of 2023 National surveillance; cases fell sharply after 2017 (martelli2024clinicalspectrumof pages 1-2)
Brazil 2023 reported Zika cases 54,116 cases; incidence 25/100,000; 6,201 laboratory confirmed Brazil, 2023 Brazil accounted for 97% of reported Americas cases in preliminary 2023 surveillance (rabe2025areviewof pages 4-5)
Preliminary Americas Zika cases in 2023 55,813 cases from 14 countries; 4 deaths Americas, 2023 preliminary surveillance 11% laboratory confirmed (rabe2025areviewof pages 4-5)

Table: These tables summarize the main congenital Zika syndrome phenotypes with quantitative frequency estimates and the most useful recent epidemiology statistics. They are designed for rapid knowledge-base extraction and link each major claim to supporting context IDs.

Key statistics from pooled and review evidence include: - Neuroimaging hallmarks: calcifications and ventriculomegaly are among the most consistent abnormalities (often ~80% in pooled cohorts; very high proportions in clinicopathologic summaries). (mirandafilho2025characterizationof843 pages 2-3, shah2024analysisofcongenital pages 13-15) - Epilepsy: reported prevalence varies with ascertainment/severity and follow-up, ranging from ~30–80% across pooled cohorts and up to ~71% cumulative incidence by age 2 in some microcephaly cohorts. (martelli2024clinicalspectrumof pages 2-3, mirandafilho2025characterizationof843 pages 2-3) - Feeding/swallowing dysfunction: dysphagia is frequently reported (broad ranges across cohorts/reviews), with severe oropharyngeal dysphagia particularly enriched among children with Zika-related microcephaly. (martelli2024clinicalspectrumof pages 3-4)

3.3 Age of onset, progression, severity

  • Onset: Congenital, with abnormalities present at birth or emerging postnatally (e.g., postnatal microcephaly can occur). (mirandafilho2025characterizationof843 pages 2-3)
  • Progression: Many outcomes are chronic and severe, including persistent motor impairment and epilepsy; severe disability drives long-term care needs. (martelli2024clinicalspectrumof pages 3-4, shah2024analysisofcongenital pages 13-15)

3.4 Quality of life and family impact

A 2023 integrative review (31 studies) described caregiver burdens spanning social, psychological, economic/material, and health domains, with quantified mental-health burdens in some studies (e.g., 40% mild-to-severe depressive symptoms in one study; 24% mild-to-severe anxiety; 13% high/clinically relevant stress in another). Publication date: 2023-05; URL: https://doi.org/10.1590/1413-81232023285.14852022en (melo2023congenitalzikasyndrome pages 11-12)

4. Genetic / Molecular Information

4.1 Causal genes

CZS is not classically a monogenic disease; the causal factor is infectious (ZIKV). However, host genetic modifiers of susceptibility and severity have been reported. (santos2023associationbetweengenetic pages 1-2, marques2025geneticmodifiersof pages 10-13)

4.2 Pathogenic variants / modifier loci (host genetics)

A 2023 case–control candidate-gene study (Brazil; 245 individuals including mother–infant pairs) reported associations between: - TREM1 rs2234246 with CZS occurrence (e.g., CC genotype OR reported ~4.91 in one comparison; log-additive effects in mothers and children), and - CXCL8 rs4073 and TLR7 rs179008 with severity of microcephaly in affected children. Publication date: 2023-03; URL: https://doi.org/10.1038/s41598-023-30342-3 (santos2023associationbetweengenetic pages 4-5, santos2023associationbetweengenetic pages 1-2)

A 2025 scoping review summarized 23 candidate genes across 13 studies (mixed designs including WES, discordant twin transcriptomics, and candidate-gene cohorts) as potential modifiers; named examples include MTOR (rs2295079) and immune-pathway polymorphisms (e.g., IL28B rs8099917, TNF variants) while emphasizing small sample sizes and need for replication. Publication date: 2025-01; URL: https://doi.org/10.1101/2025.01.02.25319896 (marques2025geneticmodifiersof pages 10-13)

4.3 Epigenetics and chromosomal abnormalities

No specific epigenetic signatures or recurrent chromosomal abnormalities were identified in the retrieved evidence for this run.

5. Environmental Information

5.1 Infectious agent

  • Pathogen: Zika virus (ZIKV), primarily mosquito-borne (Aedes spp.) with additional sexual and vertical transmission routes. (rabe2025areviewof pages 1-2, martelli2024clinicalspectrumof pages 1-2)

5.2 Environmental/lifestyle contributors

Environmental conditions that facilitate Aedes proliferation (standing water, household exposure, and broader ecological suitability) indirectly increase risk of maternal infection; prevention focuses on vector control and personal protective measures. (crisantolopez2023congenitalzikasyndrome pages 8-10)

6. Mechanism / Pathophysiology (current model)

6.1 Causal chain from trigger to clinical manifestations

Trigger: Maternal ZIKV infection during pregnancy → placental infection and vertical transmission → fetal CNS infection and/or placental insufficiency/inflammatory injury → neurodevelopmental disruption → congenital malformations and long-term neurologic disability. (wong2025zikavirusand pages 3-5, wong2025zikavirusand pages 1-2)

Key mechanistic steps supported by recent reviews: 1. Placental tropism and vertical transmission: ZIKV infects placental cell types including undifferentiated cytotrophoblasts and Hofbauer cells (placental macrophages), establishing intra-placental replication/persistence that can facilitate transfer to fetal circulation. (wong2025zikavirusand pages 3-5) 2. Entry factors and receptors: Receptor/attachment factor usage includes AXL, TYRO3, and TIM1 (including on Hofbauer cells and trophoblast-associated compartments); placental-interface reviews describe receptor-mediated entry as contributory but potentially redundant across systems. (crisantolopez2023congenitalzikasyndrome pages 4-5, wong2025zikavirusand pages 3-5) 3. Innate immune evasion: ZIKV NS5 antagonizes type I interferon responses by promoting STAT2 degradation, suppressing interferon-stimulated gene programs and enabling dissemination. (crisantolopez2023congenitalzikasyndrome pages 4-5, wong2025zikavirusand pages 3-5) 4. Neural progenitor injury: ZIKV infects radial glia/neural progenitors; congenital neuropathogenesis reviews emphasize cell cycle dysregulation, mitochondrial fragmentation, ER stress/unfolded protein response, and p53-mediated intrinsic apoptosis as central pathways leading to loss of progenitor pools and microcephaly. (metzler2024zikavirusneuropathogenesis—research pages 1-2) 5. Inflammation and placental dysfunction: Infection triggers inflammatory signaling, oxidative/ER stress, and metabolic reprogramming in placental cells, contributing to placental insufficiency and adverse fetal outcomes; maternal immune activation cytokines (e.g., IL-6, TNF-α) are implicated in amplifying fetal neurodevelopmental injury. (wong2025zikavirusand pages 1-2, wong2025zikavirusand pages 3-5)

6.2 Suggested ontology terms (examples)

  • GO biological process (suggested): type I interferon signaling pathway; response to virus; apoptotic process; ER stress response / unfolded protein response; regulation of cell cycle; neurogenesis. (metzler2024zikavirusneuropathogenesis—research pages 1-2, crisantolopez2023congenitalzikasyndrome pages 4-5)
  • Cell types (CL, suggested): Hofbauer cell (placental macrophage); trophoblast subtypes (cytotrophoblast/extravillous trophoblast/syncytiotrophoblast); radial glia; neural progenitor cell; microglia. (wong2025zikavirusand pages 3-5, metzler2024zikavirusneuropathogenesis—research pages 1-2)

7. Anatomical Structures Affected

7.1 Primary organs and systems

  • CNS/brain: primary target; includes cortical development abnormalities, ventriculomegaly, calcifications, and brain parenchymal loss. (martelli2024clinicalspectrumof pages 2-3, shah2024analysisofcongenital pages 13-15)
  • Eye/visual system: retinal and optic nerve lesions. (shah2024analysisofcongenital pages 10-12, shah2024analysisofcongenital pages 13-15)
  • Musculoskeletal system: congenital contractures/arthrogryposis and long-term spasticity/hypertonia. (martelli2024clinicalspectrumof pages 1-2, shah2024analysisofcongenital pages 13-15)

7.2 Tissue/cell level localization

Placenta (trophoblast lineages and fetal macrophages) is a key site of replication/persistence relevant to transmission; fetal neurogenic zones (ventricular/subventricular regions) are implicated in neural progenitor injury. (wong2025zikavirusand pages 3-5, shah2024analysisofcongenital pages 13-15)

8. Temporal Development (onset and progression)

  • Onset: congenital; may present at birth or evolve (e.g., postnatal microcephaly). (mirandafilho2025characterizationof843 pages 2-3)
  • Critical period: First-trimester maternal infection is strongly associated with higher risk of adverse outcomes in at least one controlled cohort. (venancio2025earlyandlongterm pages 1-3)

9. Inheritance and Population

9.1 Epidemiology and geographic distribution

  • As of December 2023, autochthonous mosquito-borne ZIKV transmission had been documented in 92 countries/territories. Publication date: 2025-02; URL: https://doi.org/10.4269/ajtmh.24-0420 (rabe2025areviewof pages 1-2)
  • In Brazil, surveillance recorded 1,858 confirmed CZS cases between 2015 and epidemiological week 31 of 2023, with a large number of suspected cases under investigation. (martelli2024clinicalspectrumof pages 1-2)
  • A systematic review/meta-analysis estimated CZS among infected pregnancies: 4.65% (95% CI 3.38–6.67%). (mccain2026asystematicreview pages 1-2)

9.2 Sex ratio / demographic patterns

The retrieved evidence did not provide a consistent, pooled sex ratio for CZS; cohort-level details exist but were not systematically extractable from the provided snippets.

10. Diagnostics

10.1 Laboratory testing and key constraints

Recent diagnostic synthesis emphasizes two major limitations: - Short NAT window in blood due to transient viremia (often within ~≤7 days of symptom onset), and - Serologic cross-reactivity among flaviviruses (especially dengue vs Zika), complicating IgG/IgM interpretation and requiring confirmatory neutralization testing (PRNT). Publication date: 2025-04; URL: https://doi.org/10.1038/s44298-025-00114-z (madere2025flavivirusinfectionsand pages 5-6, madere2025flavivirusinfectionsand pages 1-2)

10.2 Imaging

Brain CT/MRI abnormalities (cortical atrophy, ventriculomegaly, calcifications) are used as structural markers of severity and part of clinical evaluation of suspected CZS. (martelli2024clinicalspectrumof pages 1-2)

10.3 Differential diagnosis

When congenital infection is suspected, evaluation should exclude other teratogenic infections (e.g., CMV, rubella, toxoplasmosis, syphilis), which is explicitly recommended in clinical management summaries. (crisantolopez2023congenitalzikasyndrome pages 8-10)

11. Outcome / Prognosis

11.1 Neurodevelopmental outcomes after exposure (with and without CZS)

Outcomes vary markedly by whether an infant has classic CZS/microcephaly versus antenatal exposure without congenital findings. - In a matched cohort (Brazil), in utero exposure was associated with IRR 2.7 (95% CI 1.4–5.1) for adverse outcomes overall and increased risks of motor and cognitive delays; early gestational infection showed higher risk. (venancio2025earlyandlongterm pages 1-3) - In a Nicaragua prospective cohort of normocephalic children, adjusted preschool neurodevelopment scores did not differ significantly between exposed and unexposed groups, underscoring heterogeneity across settings and study designs. Publication date: 2024-07; URL: https://doi.org/10.1016/S2214-109X(24)00176-1 (max2024neurodevelopmentinpreschool pages 1-3)

11.2 Mortality

A 2024 systematic clinicopathologic review summarized markedly increased early-childhood mortality in severe CZS presentations (reported as ~11.3-fold higher risk up to 36 months in one cited estimate). (shah2024analysisofcongenital pages 13-15)

12. Treatment

12.1 Current standard of care (real-world implementation)

There is no specific curative treatment for CZS; management is supportive and multidisciplinary, requiring constant monitoring, early intervention/rehabilitation, feeding/nutrition management, and management of epilepsy and motor impairment. (crisantolopez2023congenitalzikasyndrome pages 1-2, shah2024analysisofcongenital pages 13-15)

Suggested MAXO terms (examples; not exhaustively evidenced in retrieved text): - MAXO:0000102 (rehabilitation), MAXO:0000427 (physical therapy), MAXO:0000415 (speech therapy), MAXO:0000600 (nutritional support), MAXO:0000747 (seizure management) — included as ontology suggestions based on the supportive-care emphasis. (shah2024analysisofcongenital pages 13-15, crisantolopez2023congenitalzikasyndrome pages 8-10)

12.2 Experimental / investigational countermeasures

Preclinical evidence summarized in an animal-model review notes repurposed antivirals (e.g., sofosbuvir) in nonhuman primate contexts, but these are not established human therapies for congenital disease in the retrieved evidence. (gardinali2025congenitalzikavirus pages 3-4)

13. Prevention

13.1 Primary prevention

Prevention focuses on reducing maternal infection risk: - Vector control and personal protection: reduction of breeding sites, window/door screens, bed nets, covering clothing, and repellents (e.g., DEET, picaridin/icaridin) are recommended in clinical prevention summaries. (crisantolopez2023congenitalzikasyndrome pages 8-10) - Reproductive counseling and sexual transmission precautions: guidance on delaying conception after exposure and barrier protection for partners is described in clinical guidance summaries. (crisantolopez2023congenitalzikasyndrome pages 8-10)

13.2 Vaccines (status: clinical development, not licensed)

Multiple Zika vaccines have been evaluated in clinical trials; several have completed early-phase studies: - mRNA vaccine (mRNA-1893; Moderna): Phase 2, randomized observer-blind placebo-controlled; COMPLETED; enrollment 808; completion date 2024-07-26; results posted Sept 2025. ClinicalTrials.gov: NCT04917861. (NCT04917861 chunk 1) - DNA vaccine (VRC 5283 plasmid; NIAID): Phase 2/2B randomized vaccine vs placebo; COMPLETED; enrollment 2428; completed 2019-10-04. ClinicalTrials.gov: NCT03110770. (NCT03110770 chunk 1) - Inactivated whole-virus vaccine (VLA1601; Valneva): Phase 1 randomized double-blind dose-finding; COMPLETED; ~150 participants; two-dose regimen (Day 1/29). ClinicalTrials.gov: NCT06334393. (NCT06334393 chunk 1)

These trials are aimed at preventing ZIKV infection (and downstream congenital disease) but do not constitute current standard-of-care prevention in routine practice given the absence of a licensed vaccine in the retrieved evidence. (rabe2025areviewof pages 1-2, NCT04917861 chunk 1)

14. Other Species / Natural Disease

ZIKV congenital outcomes are modeled across species; the evidence here primarily supports experimental susceptibility rather than naturally occurring veterinary disease burdens.

15. Model Organisms (mechanism and translational research)

15.1 Major model systems and what they recapitulate

  • Human brain organoids / iPSC-derived neural progenitors: reproduce preferential infection of neural progenitors and outcomes such as reduced organoid size, thinner cortical layers, and increased cell death; useful for mechanistic dissection and therapeutic screening but lower throughput and complex. (metzler2024zikavirusneuropathogenesis—research pages 13-14)
  • Mouse models (often IFN-pathway modified or humanized): widely used but require immune manipulation because ZIKV immune-evasion interactions (e.g., NS5–STAT2) are species-specific; models can reproduce fetal loss, growth restriction, brain malformations, and neurodevelopmental phenotypes. (metzler2024zikavirusneuropathogenesis—research pages 13-14, horvath2025ahumanizedmouse pages 1-5)
  • Nonhuman primates (rhesus macaques): high translational relevance for placental infection and fetal outcomes; costly and lower throughput; reported fetal demise around ~26% in early gestation infection in one summary. (metzler2024zikavirusneuropathogenesis—research pages 13-14)

15.2 Limitations

Key limitations include differences in placentation/anatomy and interferon biology across species, and the need for immune suppression/genetic modification in many rodent studies, which can distort the human-like spectrum. (gardinali2025congenitalzikavirus pages 2-3, metzler2024zikavirusneuropathogenesis—research pages 13-14)

Expert opinion and synthesis (authoritative analyses)

  • Surveillance-focused experts emphasize that ZIKV remains a public-health threat due to re-emergence potential, diagnostic limitations, and ongoing transmission across many regions, recommending targeted surveillance and clear testing algorithms. (rabe2025areviewof pages 1-2)
  • Brazil-focused clinical experts stress heterogeneity of outcomes (including children without abnormalities at birth) and the need for standardized protocols and long-term cohort follow-up with appropriate controls. (martelli2024clinicalspectrumof pages 1-2, martelli2024clinicalspectrumof pages 3-4)

Evidence limitations / gaps for knowledge-base completion

  • Formal identifiers beyond ICD-11 KA62.0 (e.g., MONDO, Orphanet, ICD-10, MeSH descriptor specifically for congenital Zika syndrome) were not directly retrievable in the provided full-text evidence, and should be filled by direct ontology lookup (e.g., ICD-11 MMS browser, MONDO, MeSH). (martelli2024clinicalspectrumof pages 2-3, crisantolopez2023congenitalzikasyndrome pages 8-10)
  • Some mechanistic claims remain model-dependent; receptor usage and ADE-related hypotheses require careful interpretation and human validation. (wong2025zikavirusand pages 2-3)

References

  1. (martelli2024clinicalspectrumof pages 1-2): Celina Maria Turchi Martelli, Fanny Cortes, Sinval Pinto Brandão-Filho, Marilia Dalva Turchi, Wayner Vieira de Souza, Thalia Velho Barreto de Araújo, Ricardo Arraes de Alencar Ximenes, and Demócrito de Barros Miranda-Filho. Clinical spectrum of congenital zika virus infection in brazil: update and issues for research development. Revista da Sociedade Brasileira de Medicina Tropical, Jul 2024. URL: https://doi.org/10.1590/0037-8682-0153-2024, doi:10.1590/0037-8682-0153-2024. This article has 12 citations.

  2. (crisantolopez2023congenitalzikasyndrome pages 1-2): Israel E. Crisanto-López, Pablo López-De Jesús, Jacqueline López-Quecho, and Juan C. Flores-Alonso. Congenital zika syndrome. Boletín Médico del Hospital Infantil de México, Mar 2023. URL: https://doi.org/10.24875/bmhim.22000110, doi:10.24875/bmhim.22000110. This article has 15 citations.

  3. (martelli2024clinicalspectrumof pages 2-3): Celina Maria Turchi Martelli, Fanny Cortes, Sinval Pinto Brandão-Filho, Marilia Dalva Turchi, Wayner Vieira de Souza, Thalia Velho Barreto de Araújo, Ricardo Arraes de Alencar Ximenes, and Demócrito de Barros Miranda-Filho. Clinical spectrum of congenital zika virus infection in brazil: update and issues for research development. Revista da Sociedade Brasileira de Medicina Tropical, Jul 2024. URL: https://doi.org/10.1590/0037-8682-0153-2024, doi:10.1590/0037-8682-0153-2024. This article has 12 citations.

  4. (NCT03110770 chunk 4): VRC 705: A Zika Virus DNA Vaccine in Healthy Adults and Adolescents. National Institute of Allergy and Infectious Diseases (NIAID). 2017. ClinicalTrials.gov Identifier: NCT03110770

  5. (crisantolopez2023congenitalzikasyndrome pages 8-10): Israel E. Crisanto-López, Pablo López-De Jesús, Jacqueline López-Quecho, and Juan C. Flores-Alonso. Congenital zika syndrome. Boletín Médico del Hospital Infantil de México, Mar 2023. URL: https://doi.org/10.24875/bmhim.22000110, doi:10.24875/bmhim.22000110. This article has 15 citations.

  6. (mirandafilho2025characterizationof843 pages 2-3): Demócrito de Barros Miranda-Filho, Ricardo Arraes de Alencar Ximenes, Ulisses Ramos Montarroyos, Marília Rosa Abtibol-Bernardino, Elizabeth B. Brickley, Celina Maria Turchi Martelli, Laura Cunha Rodrigues, Thália Velho Barreto de Araújo, Liana O. Ventura, Mariana Carvalho Leal, Darci Neves Santos, Letícia Marques dos Santos, Lucas Monteiro Santos, Mariana Rabelo Gomes, Isadora Cristina de Siqueira, Letícia Serra, Débora Patrícia Medeiros Santos Rios, Alessandra Carvalho, Antônio Moura Silva, Patrícia Silva Sousa, Marizélia Costa Ribeiro, Marcos Garcia Campos, Saulo Duarte Passos, Ana Paula Paschoalicchio Bertozzi, Rosa Estela Gazeta, Daniel T. Catalan, Ricardo Queiroz Gurgel, Aline de Siqueira Alves Lopes, Andrea Monteiro Correia Medeiros, Patrícia Brasil, Karin Nielsen-Saines, Zilton Vasconcelos, Andrea Araújo Zin, Marisa Márcia Mussi-Pinhata, Silvia Fabiana Biason de Moura Negrini, Bento Vidal de Moura Negrini, Carla Andrea Cardoso Tanuri Caldas, Daniela Vivacqua, Bernadete Perez Coelho, Lucíola de Fátima Albuquerque de Almeida Peixoto, Camila Bôtto-Menezes, Silvana Gomes Benzecry, Consuelo Silva de Oliveira, Joelma Karin Sagica Fernandes Paschoal, Emilene Monteiro Furtado Serra, Luna Thais Sousa Gomes, Maria Elisabeth Moreira, and Cristina Barroso Hofer. Characterization of 843 children with zika-related microcephaly in the first three years of life: an individual participant data meta-analysis of 12 cohorts in the zika brazilian cohorts consortium. PLOS Global Public Health, 5(12):e0005425, Dec 2025. URL: https://doi.org/10.1371/journal.pgph.0005425, doi:10.1371/journal.pgph.0005425. This article has 1 citations and is from a peer-reviewed journal.

  7. (rabe2025areviewof pages 4-5): Ingrid B. Rabe, Susan L. Hills, Joana M. Haussig, Allison T. Walker, Thais dos Santos, José Luis San Martin, Gamaliel Gutierrez, Jairo Mendez-Rico, José Cruz Rodriguez, Douglas Elizondo-Lopez, Gabriel Gonzalez-Escobar, Emmanuel Chanda, Samira M. Al Eryani, Chiori Kodama, Aya Yajima, Manish Kakkar, Masaya Kato, Pushpa R. Wijesinghe, Sudath Samaraweera, Hannah Brindle, Hasitha Tissera, James Kelley, Eve Lackritz, and Diana P. Rojas. A review of the recent epidemiology of zika virus infection. The American Journal of Tropical Medicine and Hygiene, 112:1026-1035, Feb 2025. URL: https://doi.org/10.4269/ajtmh.24-0420, doi:10.4269/ajtmh.24-0420. This article has 63 citations.

  8. (melo2023congenitalzikasyndrome pages 11-12): Ana Paula Lopes de Melo, Tereza Maciel Lyra, Jessyka Mary Vasconcelos Barbosa, and Thália Velho Barreto de Araújo. Congenital zika syndrome and family impacts: an integrative review. Ciência & Saúde Coletiva, May 2023. URL: https://doi.org/10.1590/1413-81232023285.14852022en, doi:10.1590/1413-81232023285.14852022en. This article has 14 citations.

  9. (crisantolopez2023congenitalzikasyndrome pages 4-5): Israel E. Crisanto-López, Pablo López-De Jesús, Jacqueline López-Quecho, and Juan C. Flores-Alonso. Congenital zika syndrome. Boletín Médico del Hospital Infantil de México, Mar 2023. URL: https://doi.org/10.24875/bmhim.22000110, doi:10.24875/bmhim.22000110. This article has 15 citations.

  10. (wong2025zikavirusand pages 3-5): Sam Chak Sum Wong, Joshua Fung, Pak-Ting Hau, Yanjie Guo, Philip C. N. Chiu, Hong Wa Yung, Gilman Kit Hang Siu, Franklin Wang-Ngai Chow, and Cheuk-Lun Lee. Zika virus and the fetal-maternal interface: deciphering the mechanisms of placental infection and implications for pregnancy outcomes. Jul 2025. URL: https://doi.org/10.1080/22221751.2025.2532681, doi:10.1080/22221751.2025.2532681. This article has 6 citations and is from a domain leading peer-reviewed journal.

  11. (venancio2025earlyandlongterm pages 1-3): Fabio Antonio Venancio, Maria Eulina Quilião, Sanny Cerqueira de Oliveira Gabeira, Amanda Torrentes de Carvalho, Silvia Helena dos Santos Leite, Sheila Maria Barbosa de Lima, Nathalia dos Santos Alves, Luma da Cruz Moura, Waleska Dias Schwarcz, Adriana de Souza Azevedo, Luiz Henrique Ferraz Demarchi, Marina Castilhos Souza Umaki Zardin, Gislene Garcia de Castro Lichs, Deborah Ledesma Taira, Wagner de Souza Fernandes, Natália Oliveira Alves, Aline Etelvina Casaril Arrua, Ana Isabel do Nascimento, Lisany Krug Mareto, Micael Viana de Azevedo, Camila Guadeluppe Maciel, Márcio José de Medeiros, Moreno Magalhães de Souza Rodrigues, Zilton Vasconcelos, Karin Nielsen-Saines, Rivaldo Venâncio da Cunha, Cláudia Du Bocage Santos-Pinto, and Everton Falcão de Oliveira. Early and long-term adverse outcomes of in utero zika exposure. Pediatrics, Jan 2025. URL: https://doi.org/10.1542/peds.2024-067552, doi:10.1542/peds.2024-067552. This article has 11 citations and is from a highest quality peer-reviewed journal.

  12. (mccain2026asystematicreview pages 1-2): Kelly McCain, Anna Vicco, Christian Morgenstern, Thomas Rawson, Tristan M. Naidoo, Sangeeta Bhatia, Dominic P. Dee, Patrick Doohan, Keith Fraser, Anna-Maria Hartner, Sequoia I. Leuba, Shazia Ruybal-Pesántez, Richard J. Sheppard, H. Juliette T. Unwin, Kelly Charniga, Zulma M. Cucunubá, Gina Cuomo-Dannenburg, Natsuko Imai-Eaton, Edward S. Knock, Adam Kucharski, Mantra Kusumgar, Paul Liétar, Rebecca K. Nash, Sabine van Elsland, Aaron Morris, Alpha Forna, Amy Dighe, Anna-Maria Hartner, Anne Cori, Arran Hamlet, Ben Lambert, Bethan Cracknell Daniels, Charles Whittaker, Cosmo Santoni, Cyril Geismar, Dariya Nikitin, David Jorgensen, Dominic P. Dee, Edward S. Knock, Hayley Thompson, Isobel Routledge, Jack Wardle, Janetta Skarp, Joseph Hicks, Kanchan Parchani, Kieran Drake, Lily Geidelberg, Lorenzo Cattarino, Mara Kont, Marc Baguelin, Pablo N. Perez-Guzman, Paula Christen, Rebecca Nash, Richard Fitzjohn, Richard Sheppard, Rob Johnson, Sabine van Elsland, Sequoia I. Leuba, Shazia Ruybal-Pesántez, Sreejith Radhakrishnan, Tristan M. Naidoo, Zulma M. Cucunubá, Nuno R. Faria, Anne Cori, Ruth McCabe, and Ilaria Dorigatti. A systematic review and meta-analysis of zika virus epidemiology. Nature Health, 1:355-367, Feb 2026. URL: https://doi.org/10.1038/s44360-025-00051-4, doi:10.1038/s44360-025-00051-4. This article has 1 citations.

  13. (shah2024analysisofcongenital pages 13-15): Dhaara Shah, Dhairavi Shah, Olivia Mua, and Rana Zeine. Analysis of congenital zika syndrome clinicopathologic findings reported in the 8 years since the brazilian outbreak. Exploration of Neuroprotective Therapy, pages 82-99, Feb 2024. URL: https://doi.org/10.37349/ent.2024.00072, doi:10.37349/ent.2024.00072. This article has 3 citations.

  14. (wong2025zikavirusand pages 2-3): Sam Chak Sum Wong, Joshua Fung, Pak-Ting Hau, Yanjie Guo, Philip C. N. Chiu, Hong Wa Yung, Gilman Kit Hang Siu, Franklin Wang-Ngai Chow, and Cheuk-Lun Lee. Zika virus and the fetal-maternal interface: deciphering the mechanisms of placental infection and implications for pregnancy outcomes. Jul 2025. URL: https://doi.org/10.1080/22221751.2025.2532681, doi:10.1080/22221751.2025.2532681. This article has 6 citations and is from a domain leading peer-reviewed journal.

  15. (martelli2024clinicalspectrumof pages 3-4): Celina Maria Turchi Martelli, Fanny Cortes, Sinval Pinto Brandão-Filho, Marilia Dalva Turchi, Wayner Vieira de Souza, Thalia Velho Barreto de Araújo, Ricardo Arraes de Alencar Ximenes, and Demócrito de Barros Miranda-Filho. Clinical spectrum of congenital zika virus infection in brazil: update and issues for research development. Revista da Sociedade Brasileira de Medicina Tropical, Jul 2024. URL: https://doi.org/10.1590/0037-8682-0153-2024, doi:10.1590/0037-8682-0153-2024. This article has 12 citations.

  16. (shah2024analysisofcongenital pages 10-12): Dhaara Shah, Dhairavi Shah, Olivia Mua, and Rana Zeine. Analysis of congenital zika syndrome clinicopathologic findings reported in the 8 years since the brazilian outbreak. Exploration of Neuroprotective Therapy, pages 82-99, Feb 2024. URL: https://doi.org/10.37349/ent.2024.00072, doi:10.37349/ent.2024.00072. This article has 3 citations.

  17. (shah2024analysisofcongenital pages 1-3): Dhaara Shah, Dhairavi Shah, Olivia Mua, and Rana Zeine. Analysis of congenital zika syndrome clinicopathologic findings reported in the 8 years since the brazilian outbreak. Exploration of Neuroprotective Therapy, pages 82-99, Feb 2024. URL: https://doi.org/10.37349/ent.2024.00072, doi:10.37349/ent.2024.00072. This article has 3 citations.

  18. (mccain2026asystematicreview pages 7-7): Kelly McCain, Anna Vicco, Christian Morgenstern, Thomas Rawson, Tristan M. Naidoo, Sangeeta Bhatia, Dominic P. Dee, Patrick Doohan, Keith Fraser, Anna-Maria Hartner, Sequoia I. Leuba, Shazia Ruybal-Pesántez, Richard J. Sheppard, H. Juliette T. Unwin, Kelly Charniga, Zulma M. Cucunubá, Gina Cuomo-Dannenburg, Natsuko Imai-Eaton, Edward S. Knock, Adam Kucharski, Mantra Kusumgar, Paul Liétar, Rebecca K. Nash, Sabine van Elsland, Aaron Morris, Alpha Forna, Amy Dighe, Anna-Maria Hartner, Anne Cori, Arran Hamlet, Ben Lambert, Bethan Cracknell Daniels, Charles Whittaker, Cosmo Santoni, Cyril Geismar, Dariya Nikitin, David Jorgensen, Dominic P. Dee, Edward S. Knock, Hayley Thompson, Isobel Routledge, Jack Wardle, Janetta Skarp, Joseph Hicks, Kanchan Parchani, Kieran Drake, Lily Geidelberg, Lorenzo Cattarino, Mara Kont, Marc Baguelin, Pablo N. Perez-Guzman, Paula Christen, Rebecca Nash, Richard Fitzjohn, Richard Sheppard, Rob Johnson, Sabine van Elsland, Sequoia I. Leuba, Shazia Ruybal-Pesántez, Sreejith Radhakrishnan, Tristan M. Naidoo, Zulma M. Cucunubá, Nuno R. Faria, Anne Cori, Ruth McCabe, and Ilaria Dorigatti. A systematic review and meta-analysis of zika virus epidemiology. Nature Health, 1:355-367, Feb 2026. URL: https://doi.org/10.1038/s44360-025-00051-4, doi:10.1038/s44360-025-00051-4. This article has 1 citations.

  19. (rabe2025areviewof pages 1-2): Ingrid B. Rabe, Susan L. Hills, Joana M. Haussig, Allison T. Walker, Thais dos Santos, José Luis San Martin, Gamaliel Gutierrez, Jairo Mendez-Rico, José Cruz Rodriguez, Douglas Elizondo-Lopez, Gabriel Gonzalez-Escobar, Emmanuel Chanda, Samira M. Al Eryani, Chiori Kodama, Aya Yajima, Manish Kakkar, Masaya Kato, Pushpa R. Wijesinghe, Sudath Samaraweera, Hannah Brindle, Hasitha Tissera, James Kelley, Eve Lackritz, and Diana P. Rojas. A review of the recent epidemiology of zika virus infection. The American Journal of Tropical Medicine and Hygiene, 112:1026-1035, Feb 2025. URL: https://doi.org/10.4269/ajtmh.24-0420, doi:10.4269/ajtmh.24-0420. This article has 63 citations.

  20. (rabe2025areviewof pages 3-4): Ingrid B. Rabe, Susan L. Hills, Joana M. Haussig, Allison T. Walker, Thais dos Santos, José Luis San Martin, Gamaliel Gutierrez, Jairo Mendez-Rico, José Cruz Rodriguez, Douglas Elizondo-Lopez, Gabriel Gonzalez-Escobar, Emmanuel Chanda, Samira M. Al Eryani, Chiori Kodama, Aya Yajima, Manish Kakkar, Masaya Kato, Pushpa R. Wijesinghe, Sudath Samaraweera, Hannah Brindle, Hasitha Tissera, James Kelley, Eve Lackritz, and Diana P. Rojas. A review of the recent epidemiology of zika virus infection. The American Journal of Tropical Medicine and Hygiene, 112:1026-1035, Feb 2025. URL: https://doi.org/10.4269/ajtmh.24-0420, doi:10.4269/ajtmh.24-0420. This article has 63 citations.

  21. (santos2023associationbetweengenetic pages 1-2): Camilla Natália Oliveira Santos, Lucas Sousa Magalhães, Adriana Barbosa de Lima Fonseca, Ana Jovina Barreto Bispo, Roseane Lima Santos Porto, Juliana Cardoso Alves, Cliomar Alves dos Santos, Jaira Vanessa de Carvalho, Angela Maria da Silva, Mauro Martins Teixeira, Roque Pacheco de Almeida, Priscila Lima dos Santos, and Amélia Ribeiro de Jesus. Association between genetic variants in trem1, cxcl10, il4, cxcl8 and tlr7 genes with the occurrence of congenital zika syndrome and severe microcephaly. Scientific Reports, Mar 2023. URL: https://doi.org/10.1038/s41598-023-30342-3, doi:10.1038/s41598-023-30342-3. This article has 22 citations and is from a peer-reviewed journal.

  22. (marques2025geneticmodifiersof pages 10-13): Fernanda J P Marques, Janet Ruan, Rozel B. Razal, Marcio Leyser, and Youssef A. Kousa. Genetic modifiers of prenatal brain injury after zika virus infection: a scoping review. medRxiv : the preprint server for health sciences, Jan 2025. URL: https://doi.org/10.1101/2025.01.02.25319896, doi:10.1101/2025.01.02.25319896. This article has 0 citations.

  23. (santos2023associationbetweengenetic pages 4-5): Camilla Natália Oliveira Santos, Lucas Sousa Magalhães, Adriana Barbosa de Lima Fonseca, Ana Jovina Barreto Bispo, Roseane Lima Santos Porto, Juliana Cardoso Alves, Cliomar Alves dos Santos, Jaira Vanessa de Carvalho, Angela Maria da Silva, Mauro Martins Teixeira, Roque Pacheco de Almeida, Priscila Lima dos Santos, and Amélia Ribeiro de Jesus. Association between genetic variants in trem1, cxcl10, il4, cxcl8 and tlr7 genes with the occurrence of congenital zika syndrome and severe microcephaly. Scientific Reports, Mar 2023. URL: https://doi.org/10.1038/s41598-023-30342-3, doi:10.1038/s41598-023-30342-3. This article has 22 citations and is from a peer-reviewed journal.

  24. (wong2025zikavirusand pages 1-2): Sam Chak Sum Wong, Joshua Fung, Pak-Ting Hau, Yanjie Guo, Philip C. N. Chiu, Hong Wa Yung, Gilman Kit Hang Siu, Franklin Wang-Ngai Chow, and Cheuk-Lun Lee. Zika virus and the fetal-maternal interface: deciphering the mechanisms of placental infection and implications for pregnancy outcomes. Jul 2025. URL: https://doi.org/10.1080/22221751.2025.2532681, doi:10.1080/22221751.2025.2532681. This article has 6 citations and is from a domain leading peer-reviewed journal.

  25. (metzler2024zikavirusneuropathogenesis—research pages 1-2): Anna D. Metzler and Hengli Tang. Zika virus neuropathogenesis—research and understanding. Pathogens, 13:555, Jul 2024. URL: https://doi.org/10.3390/pathogens13070555, doi:10.3390/pathogens13070555. This article has 23 citations.

  26. (madere2025flavivirusinfectionsand pages 5-6): Ferralita S. Madere, Aurea Virginia Andrade da Silva, Efemena Okeze, Emma Tilley, Andriyan Grinev, Krishnamurthy Konduru, Mayra García, and Maria Rios. Flavivirus infections and diagnostic challenges for dengue, west nile and zika viruses. npj Viruses, Apr 2025. URL: https://doi.org/10.1038/s44298-025-00114-z, doi:10.1038/s44298-025-00114-z. This article has 43 citations.

  27. (madere2025flavivirusinfectionsand pages 1-2): Ferralita S. Madere, Aurea Virginia Andrade da Silva, Efemena Okeze, Emma Tilley, Andriyan Grinev, Krishnamurthy Konduru, Mayra García, and Maria Rios. Flavivirus infections and diagnostic challenges for dengue, west nile and zika viruses. npj Viruses, Apr 2025. URL: https://doi.org/10.1038/s44298-025-00114-z, doi:10.1038/s44298-025-00114-z. This article has 43 citations.

  28. (max2024neurodevelopmentinpreschool pages 1-3): Ryan Max, Christian Toval-Ruiz, Sylvia Becker-Dreps, Anna M Gajewski, Evelin Martinez, Kaitlyn Cross, Bryan Blette, Oscar Ortega, Damaris Collado, Omar Zepeda, Itziar Familiar, Michael J Boivin, Meylin Chavarria, María José Meléndez, Juan Carlos Mercado, Aravinda de Silva, Matthew H Collins, Daniel Westreich, Sandra Bos, Eva Harris, Angel Balmaseda, Emily W Gower, Natalie M Bowman, Elizabeth Stringer, and Filemón Bucardo. Neurodevelopment in preschool children exposed and unexposed to zika virus in utero in nicaragua: a prospective cohort study. The Lancet. Global health, 12:e1129-e1138, Jul 2024. URL: https://doi.org/10.1016/s2214-109x(24)00176-1, doi:10.1016/s2214-109x(24)00176-1. This article has 7 citations.

  29. (gardinali2025congenitalzikavirus pages 3-4): Noemi Rovaris Gardinali, Renato Sergio Marchevsky, Yara Cavalcante Vieira, Marcelo Pelajo-Machado, Tatiana Kugelmeier, Juliana Gil Melgaço, Márcio Pinto Castro, Jaqueline Mendes de Oliveira, and Marcelo Alves Pinto. Congenital zika virus infection in laboratory animals: a comparative review highlights translational studies on the maternal-foetal interface. Memórias do Instituto Oswaldo Cruz, Feb 2025. URL: https://doi.org/10.1590/0074-02760240125, doi:10.1590/0074-02760240125. This article has 1 citations.

  30. (NCT04917861 chunk 1): A Study of Zika Vaccine mRNA-1893 in Adult Participants Living in Endemic and Non-Endemic Flavivirus Areas. ModernaTX, Inc.. 2021. ClinicalTrials.gov Identifier: NCT04917861

  31. (NCT03110770 chunk 1): VRC 705: A Zika Virus DNA Vaccine in Healthy Adults and Adolescents. National Institute of Allergy and Infectious Diseases (NIAID). 2017. ClinicalTrials.gov Identifier: NCT03110770

  32. (NCT06334393 chunk 1): Phase 1 Trial to Assess the Safety and Immunogenicity of an Inactivated, Adjuvanted Whole Zika Virus Vaccine Candidate (VLA1601) in Healthy Adults. Valneva Austria GmbH. 2024. ClinicalTrials.gov Identifier: NCT06334393

  33. (metzler2024zikavirusneuropathogenesis—research pages 13-14): Anna D. Metzler and Hengli Tang. Zika virus neuropathogenesis—research and understanding. Pathogens, 13:555, Jul 2024. URL: https://doi.org/10.3390/pathogens13070555, doi:10.3390/pathogens13070555. This article has 23 citations.

  34. (horvath2025ahumanizedmouse pages 1-5): Allison R. Horvath, Clara M. Abdelmalek, Eunbin Park, Aubrey P. Alexander, Sadhana A. Maheswaran, Arnav H. Patel, Nandi G. Patel, Janet E. Ruan, Ademide T. Adeyemo, Erin C. Li, Katherine E. Helmicki, Stephen Lin, Paul C. Wang, Zhen Li, Li Wang, Heather A. Gordish-Dressman, Tarik F. Haydar, Tamer A. Mansour, and Youssef A. Kousa. A humanized mouse model system mimics prenatal zika infection and reveals premature differentiation of neural stem cells. bioRxiv, Feb 2025. URL: https://doi.org/10.1101/2025.02.21.639556, doi:10.1101/2025.02.21.639556. This article has 2 citations.

  35. (gardinali2025congenitalzikavirus pages 2-3): Noemi Rovaris Gardinali, Renato Sergio Marchevsky, Yara Cavalcante Vieira, Marcelo Pelajo-Machado, Tatiana Kugelmeier, Juliana Gil Melgaço, Márcio Pinto Castro, Jaqueline Mendes de Oliveira, and Marcelo Alves Pinto. Congenital zika virus infection in laboratory animals: a comparative review highlights translational studies on the maternal-foetal interface. Memórias do Instituto Oswaldo Cruz, Feb 2025. URL: https://doi.org/10.1590/0074-02760240125, doi:10.1590/0074-02760240125. This article has 1 citations.

Artifacts